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ABSTRACT OF THE THESIS
Protein Preservation in Fossil Whale Bones of the Miocene/Pliocene Pisco
Formation, Peru
by
Uriel Leme Vidal
Master of Science, Graduate Program in Biology
Loma Linda University, December 2010
Dr. Leonard Brand, Chairperson

Fossil remains have recently been the focus of considerable attention due to
several independent reports of protein and soft-tissue preservation in ancient biological
remains. The fossil whales from the Pisco Formation in Peru were previously reported to
be very well preserved. A considerable percentage of these whales have their bones still
articulated, and not a few have fossil baleen in life position.
In this study we assayed bone samples from some fossil whales for ultrastructure
preservation and the presence of original protein/proteinaceous materials. For analysis of
fine details of structural preservation we used light microscopy and Scanning Electron
Microscopy (SEM). The microscopy results indicated a surprising preservation of both
blood vessel and osteocyte shaped structures. For protein/peptide verification we used
Micro-Bicinchoninic Acid (BCA) assay for total protein determination, and Fast
Performance Liquid Chromatography (FPLC) for proteins/peptides size separation.
The FPLC fractions were analyzed by Matrix-assisted Laser Desorption/
Ionization-Time of Flight (MALDI-TOF) for a more specific identification of the
proteins/peptides sizes. Polyamide sheet Thin-Layer Chromatography was implemented
with Dansylated fossil amino acids in order to ascertain the amino acid presence in the

xviii

FPLC and the C8 Solid-phase Extraction (SPE) column elution fractions. Finally, we used
Liquid Chromatography-Mass Spectrometry (LC/MS) to obtain the fragmentation pattern
of the peptides present in the fossil sample.
The LC/MS fragmentation pattern from fossil material did not show any matching
sequence when compared to trypsin digested peptide patterns in the public databases.
Nevertheless, it showed secondary fragmentation patterns (MS/MS) characteristic of
peptidic material, which implies that it is composed of peptides, but these simply were
not cleaved by trypsin, but rather by random (probably unknown) processes. Preliminary
DE NOVO sequencing attempts showed that most of the putative peptides in the samples
are fragmented, with low molecular weight, but there was also some evidence of higher
molecular weight material. Future research is needed in order to determine the protein
identification by means of DE NOVO sequencing, and the degree of its preservation in
these fossil whales.

xix

CHAPTER ONE
INTRODUCTION

The Pisco Formation
The Neogene Pisco Formation is located in southern Peru, ~350 km south of
Lima. It has a desert climate with very little precipitation throughout the whole year.
Located near the coast, it became known for its conspicuous abundance of fossil whales.
In a study site of approximately two square kilometers, Brand et al. (2004) reported the
presence of 346 partial and complete whale skeletons.
Skeletons vary in degree of preservation but most of the whales are still
articulated, and a significant number have fossil baleen in life position. This is a
particular point of interest because, under current conditions, the baleen detaches from
the whale’s mouth in a relatively short time: from a few hours to a few days after death
(private communication with marine staff conducting taphonomy research on modern
whales).
Portions of the Pisco Formation are diatom rich, without significant evidence of
their dissolution. The high rate of diatom accumulation may imply rapid burial for the
fossil whales. Contrary to the generally observed taphonomic processes in recent whale
carcasses, little or no evidence of bioerosion is associated with the whales (Brand et al.
2004).
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Fossil bone samples brought from the Pisco Formation were analyzed in the
Biochemistry and Biology labs at Loma Linda University. Evidence of a high degree of
preservation was shown through a variety of tests described below.

Fossil Preservation History
The biochemical analysis of what are considered to be ancient fossils is a
relatively new field of study. Assumptions of the dominant theory in scientific circles
generally excluded most attempts to search for preserved biological macromolecules in
fossil remains. Finding them is deemed to be completely unexpected, in view of the
immense ages assigned to the fossils.
Notwithstanding the disincentives against unexpected discoveries in this area, the
field seems to be thriving with new, scientifically scrutinized, discoveries. There are
reports of ancient protein all over the world, with special attention to dinosaurian
preserved biomaterials, but also from birds, mammals, etc., which are causing a
revolution in the common understanding of preservation and protein decay rates.
Abelson (1954) was a pioneer in this paradigm reorganization. He showed that
amino acids were found in fossils as old as Jurassic. Weiner et al. (1976) showed that
mollusk shells from the Cretaceous still retained identifiable sequences of amino acids
that were similar to extant specimens in the same superfamily; protein segments were
recovered from a Seismosaurus dinosaur (Gurley et al. 1991); and a variety of
acumulating data on the subject has been published in peer-reviewed journals in the last
20 years. But the scientific community only felt the quake when a major breakthrough
happened when Schweitzer et al. (2005) reported soft-tissue, vessels and cell-like
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structures in Tyrannosaurus rex! From then on, this field is gaining more and more
attention. In 2007, a new report revealed a partial T-rex amino acid sequence from
collagen (Asara et al. 2007).
In order to appreciate at least in part the significance of these discoveries, one
must consider the decay, fossilization rates, protein and DNA breakdown rates, that can
be estimated by analysis in vitro and by some other means (Lindahl 1993; Bada et al.
1999; Poinar 2002), and then, consider the implications of finding remains that still retain
their soft-tissue appearance, protein content immunoreactivity, DNA fragments,
morphological and some functional characteristics (Hoss et al. 1994; Davis and Briggs
1995; Greenwood et al. 1999; Poinar 1999; Schweitzer et al. 1999a; Jackson et al. 2002;
Avci et al. 2005; Asara et al. 2007; Schweitzer et al. 2007b). In view of this, there have
been several attempts to propose viable ways by which these ancient biomolecules could
have been preserved the way they were (Eglinton et al. 1991; Smejkal and Schweitzer
2007).
Protein preservation seems unlikely to happen through very long ages due to
breakdown rates, microbial degradation, diagenesis, and amino acid racemization (Bada
et al. 1999; Poinar and Stankiewicz 1999). However, because some fossils seemed to be
exceptionally preserved, the idea that original biomolecules could also be present has
been suggested in the early 20th century (Moodie 1923).
In later decades, this idea has been strengthened more and more, and now it is
well supported (Abelson 1954; Weiner et al. 1976; Westbroek et al. 1979; Armstrong et
al. 1983; Collins et al. 1991; Schweitzer et al. 1997a; Schweitzer et al. 1999a; Schweitzer
et al. 1999b). For instance, Weiner reported that shells from the late Cretaceous period

3

yielded repeating amino acid sequences similar to extant shells of the same superfamilies,
and that the very labile methionine and cysteine amino acids also occurred in the fossils
analyzed (Weiner et al. 1976). Amino acid racemization rates have been suggested, in
some reports, as not being always consistent (Weiner et al. 1976; Westbroek et al. 1979).
For example: isoleucine is thought to epimerize to alloisoleucine in less than a million
years. However, in his samples of late Cretaceous belemnites, Westbroek et al. (1979)
found an astonishing absence of alloisoleucine, which he describes as “a most striking
feature”.
There is a vast array of researchers who have reported the presence of DNA,
polysaccharides, lipids, and protein in fossils from varied locations in the geologic
column (Abelson 1954; Shackleford and Wyckoff 1964; Thompson and Creath 1966;
Weiner et al. 1976; Westbroek et al. 1979; Hoss et al. 1994; Borja et al. 1997; Schweitzer
et al. 1997a; Poinar and Stankiewicz 1999; Schweitzer et al. 1999a; Briggs et al. 2000).
Cells and vessels from dinosaurs have been repeatedly reported (Pawlicki et al. 1966;
Nowicki et al. 1972; Pawlicki 1975; Pawlicki 1984; Schweitzer et al. 2005).
The antigenic-immunoreactive properties of fossil material have received
considerable attention (de Jong et al. 1974; Prager et al. 1980; Collins et al. 1991; Muyzer
et al. 1992; Wick et al. 2001), with positive indications that at least parts of the ancient
biomolecules are present in original form (Westbroek et al. 1979; Schweitzer et al.
1999a; Schweitzer et al. 1999b; Schweitzer et al. 2002; Schweitzer et al. 2007a). Some
went even a further step to show that there can be specific immunological reactions
between ancient material and close corresponding animals living today (de Jong et al.
1974; Westbroek et al. 1979). With results like these, research in this field has become
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bolder, and it is with much interest that fossils are now being studied at the chemical
level.
As for proteins, researchers have reported keratin, albumin, and collagen,
osteocalcin, and others as present, at least in part, in ancient remains. Keratin and
keratinaceous structures were reported in several fossils such as dinosaurs, mammoths
and birds (Gillespie 1970; Norell et al. 1995; Schweitzer et al. 1999a; Schweitzer et al.
1999b). Regarding osteocalcin, which composes about 10-20% of the noncollagenous
proteins of bone, Muyzer et al. (1992) reported that at least some preserved
immunological properties still exist in upper Cretaceous and upper Jurassic dinosaur
specimens, and in Pliocene, Miocene, and Pleistocene mammal and reptile specimens.
There was a significantly reduced chance of contamination because immunological
results were paralleled with the analysis of a high-quality osteocalcin chemical marker: carboxyglutamic acid (Gla), which is absent in most microbes and invertebrates (Muyzer
et al. 1992), but not all (Low et al. 1980). Albumin has also been identified in ancient
biomaterial (Prager et al. 1980; Tuross 1989; Borja et al. 1997).
But of all the proteins found in fossils, collagen has received special attention, and
has been identified in a variety of them (Shackleford and Wyckoff 1964; Pawlicki et al.
1966; Towe and Urbanek 1972; Semal and Orban 1995; Schweitzer et al. 1997a; van
Klinken 1999; Tuross 2002; Schweitzer et al. 2009). Type I collagen is composed of a
triple-helix structure that in bone is composed of two 1 and one 2 polypeptide chains
(Weiner and Traub 1992). It is found in connective tissues such as tendons, cartilages, but
especially makes up the organic matrix of bone. Collins et al. (1995) conjecture that
cross-linked collagen is able to survive more than 100,000 years. The cross-links between
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collagen fibrils may be one of the reasons that collagen is relatively more resistant to
degradation.
Because water plays a major role in the process of living matter recycling, most
preserved fossils are thought to have been deposited in water-free environments
(especially in amber, tar pits, and sandy deserts). Some specimens show very little
evidence of diagenesis (Schweitzer et al. 1997a; Schweitzer et al. 1997b; Schweitzer et
al. 1999b), and should have a higher probability of original preservation. The positive
preservation of some kinds of biomolecules (e.g. proteins) increases the chances that
other groups of biomolecules (e.g. lipids, carbohydrates, DNA, etc.) might also be
preserved in the same sample (Poinar and Stankiewicz 1999; Gugerli et al. 2005;
Schweitzer et al. 2007b). The assigned ages to the geologic layers seem to be inconsistent
with these discoveries.
The fossil whales from the Miocene-Pliocene Pisco Formation in Peru are ideal
subjects for these new approaches to the search for ancient biomolecules. They are very
abundant and show a high degree of preservation, with many whales having their
skeletons either completely or partly articulated (Brand et al. 2004; Esperante et al.
2007). Some whales are located in places that show an unexpectedly high rate of diatom
accumulation, which may have contributed to their outstanding preservation. Therefore,
they make good candidates for the analysis that this project is proposing. Previous
research on these whales reported in them a creamy matrix and presence of cells after
chemical analysis (Schweitzer et al. 2007b). Consequently, we are pursuing further
analysis of the biochemical composition of these fossil whales so that important questions
can be raised and possibly answered.
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Thesis Question
This study will concentrate on answering the following question:
Are there original proteins or proteinaceous material in the fossil whale bones of
the Miocene/Pliocene Pisco Formation in Peru?

Goals
i. This research sought to find and identify original proteins or proteinaceous
material in the fossil whale bones.
ii. Also, to determine the amino acid sequence of the extracted protein or
proteinaceous material.
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Abstract
Fossil whales from the Pisco Formation in Peru were previously reported to show
a high degree of structural preservation. A considerable percentage of these whales had
their bones still articulated, and not a few still had fossil baleen in life position. In this
study we assayed the fossil whales for the presence of original protein/proteinaceous
materials. We used the Bicinchoninic Acid assay (BCA assay) for total protein
determination, and Fast Performance Liquid Chromatography (FPLC) for
proteins/peptides size separation. The fractions were then analyzed by Matrix-assisted
Laser Desorption/Ionization-Time of Flight (MALDI-TOF) for a more specific
determination of the proteins/peptides sizes. Finally we used Liquid ChromatographyMass Spectrometry (LC/MS) in order to determine the identity of the peptides present in
the FPLC and the C8 Solid-phase Extraction (SPE) column elution fractions. The results
showed that most of the peptides in the samples are fragmented, with low molecular
weight, with some evidence of higher molecular weight material in the sample (~ 5400
Daltons), which could be indicative of better-preserved proteins. Further research is
currently being done in order to identify the proteins and their degree of preservation in
these fossil whales.
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Introduction
Because of the dynamic nature of the Earth’s crust, and the innumerable means by
which living matter is constantly recycled, proteins were not commonly expected to be
particularly enduring, and little attention has been given to the search for proteins in
fossils. The probability of original biomolecules surviving through geologic time is
minimal. However, in recent years, research has provided an increasing number of
reports of the presence of amino acids/peptides/proteins in a variety of fossils such as
dinosaurs (Abelson 1954; Pawlicki et al. 1966; Gurley et al. 1991; Muyzer et al. 1992;
Schweitzer et al. 1997a; Schweitzer et al. 1997b; Pawlicki and Nowogrodzka-Zagorska
1998; Embery et al. 2000; Embery et al. 2003; Schweitzer et al. 2009), mammals
(Lowenstein 1980; Prager et al. 1980; Lowenstein 1981; Schweitzer et al. 2002), birds
(Schweitzer et al. 1999a), fish (Humphreys 1908; Abelson 1954), mollusks (Weiner et al.
1976; Muyzer and Westbroek 1989), and much more, all through the geologic record.
From immunologically responsive original proteins (Westbroek et al. 1979; Huq
et al. 1985; Shoshani et al. 1985; Rowley et al. 1986; Muyzer and Westbroek 1989;
Collins et al. 1991; Lowenstein et al. 1991; Borja et al. 1997; Schweitzer et al. 1999a;
Schweitzer et al. 1999b; Schweitzer et al. 2002; Avci et al. 2005) down through still soft
and pliable vessels and tissue (Avci et al. 2005; Schweitzer et al. 2005; Asara et al. 2007;
Schweitzer et al. 2007a), the search for original biomolecules in fossils has been
receiving increased attention. One of the most reported proteins in fossils is collagen
(Isaacs et al. 1963; Ho 1965; Pawlicki et al. 1966; Lowenstein 1980; Franc et al. 1995;
Avci et al. 2004; Avci et al. 2005; Schweitzer et al. 2007a), followed by a number of noncollagenous proteins such as osteocalcin, albumin, keratin, etc. The remarkable degrees
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of preservation evidenced by some recent discoveries are causing a certain stir in the
scientific community (Yeoman 2006).
The current study adds to the growing list, fossil whales from the Pisco
Formation. We’ve studied the fossil whales from the desert area of the Neogene Pisco
Formation in Peru, which were previously noticed for their remarkable degree of skeletal
articulation, and presence, in some specimens, of fossil baleen in original life position
(Esperante et al. 2007). In order for such a high preservation to occur, the fossil whales
required a very high accumulation rate of diatom and other sediment (Brand et al. 2004).
In this study we assayed the fossil bones at the molecular level in order to better
understand its preservation state. We only focused on bone samples, although it is
possible that fossil baleen remains may also contain original material. We assayed the
fossil bones in order to verify the presence of original proteins or protein fragments. The
samples were assayed in order to ascertain if they are made of peptides, and if they can be
sequenced.

Materials and Methods
Varied fossil whale bones of the Pisco Formation were screened and
experimented with. Table 2.1 shows the description of and where we obtained the extant
control samples analyzed. Table 2.2 shows the field description and original location of
the fossil samples analyzed.
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CONTROLS
Sample
Chicken
Cow
SB-Whale

Identification
Femur
Femur
Lower Jaw

Extant Whale

Unknown

Description and Location
Fresh, obtained from a local supermarket
Fresh, obtained from a local supermarket
20-year after death weathered specimen from
Santa Barbara Museum of Natural History, CA.
Very well preserved. Apparently fresh.

Table 2.1 – Control samples analyzed.

FOSSILS
Sample

Field
Identification
Rib

GPS
Position
Unknown

SP08-22
SP08-23
Sediment
SP08-23
Bone
SP08-31

(WIR05-29)
Under rib
(WIR05-29)
Rib? (WIR0529)
Vert. Lat
Process

Unknown
Unknown

SP08-32

Rib

SP08-34a

Unknown

SP08-20

Unknown
18 436 725 E
839 1311 N

EFW

Rib

18 437 550 E
839 3919 N
18 43 7553 E
839 3921 N
18 43 7553 E
839 3921 N
Unknown

BFW

Rib?

Unknown

SP08-34b

Unknown

Field Description
Tuffaceous sandstone was
stratigraphically a few centimeters
below the specimen
Unknown
Sediment (for control) which was
immediately adjacent to bone
Color is pale and bone seems to be
sandy
Body was apparently articulated and
covered, but skull was exposed and
mostly disarticulated. The bone sample
itself resembled was mineralized and
seemed a very weak candidate for any
high degree of preservation.
This whale had the baleen still
preserved in anatomical position
Whale partially disarticulated
Whale partially disarticulated
Well preserved, with a Buff color, and
with sediment completely filling the
medullary cavity
Very well preserved, with a color that
resembles the purported original white
color, common to extant whale bones

Table 2.2 – Fossil samples analyzed (including available field descriptions).
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Because of the unusual presence of blood vessel and osteocytes shapes in it, after
Ethylenediaminetetraacetic acid (EDTA) demineralization of the bone matrix, the fossil
bone sample labeled “BFW” was more extensively analyzed for protein presence. It
belonged to a very well preserved fossil baleen whale, cf. Balaenopteridae, which was
found at GPS location 18 L 8411328/422633 (datum South American ’69), that is, the
upper, diatom-rich, part of the Miocene/Pliocene Pisco Formation in Peru. The field
description of the specimen is as follows: “The entire skeleton is articulated and the
bones are well preserved, with no evidence of bioerosion or decay of the bone structure.
It also has baleen well preserved. The spinal cord has been replaced with black heavy
minerals, which are not found anywhere else in the vicinity, indicating that the mineral
was deposited in response to the chemical environment caused by soft tissue decay.”
BFW is a rib fragment of this whale. The black heavy minerals were also present
toward the center of this bone, and less so in the cortical region. The bone seems to be of
a light color, and visually appeared to have relatively less replacement than the other
bone specimens, which we also screened.

Protein Extraction
Around 50-55 g of the BFW sample was crushed with a steel mortar and pestle
into powder, both with and without using nitrogen freezing of the samples prior to
crushing. The powdered material was incubated with 400 mL of 0.5 M EDTA, pH 8.0 for
48 hours. The solution was centrifuged at 6,000 g for 1 hour and supernatant was
collected (Sup 1). The pellet was resuspended in 200 mL of 6 M Guanidine-HCl
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(GuHCl), pH 7.4 and incubated for 20 hours. The solution was centrifuged at 6,000 g for
1 hour and supernatant was collected (Sup 2).
The next step involved desalting and concentrating of the proteins in the
supernatants. Because dialysis can be inefficient and time-consuming, we chose to use a
reverse-phase solid-phase extraction column to remove the proteins from the solution and
eliminate salts and other unwanted materials. We used 8-carbon chain Solid-phase
Extraction columns (C8 PrepSep Extraction Columns, Fisher Scientific, Fair Lawn, NJ,
07410, Cat. # P452, Lot # 076082), and 18-carbon chain Solid-phase Extraction (UltraClean SPE C18 200 mg/4 mL, Grace Davison Discovery Science, 2051 Waukegan Road,
Deerfield, IL, 60015, Cat. # 505150, Lot # 50295282). The procedure was adapted from
Lawrence P. Sandberg’s protocol (personal communication).

Solid-Phase Extraction Column Protocol (C8 and C18 columns)
The procedure involved preparing the column (Wet, and Equilibrate), putting the
sample through the column (Sample), and then washing off salts (Wash), in order to
finally elute proteinaceous material (Eluate) for further analysis.
1. Wetting: 3 mL of 100% Acetonitrile (AcN)
2. Equilibrating: 3 mL of 0.1% Trifluoroacetic acid (TFA) in H2O
3. Sample: Put the whole sample through the Spin columns (100 mL/column, for
400 mL of Sup 1 used 4 columns and for 200 mL of Sup 2 used 2 columns) using
vacuum to suck it through or centrifugation.
4. Washing: 12 mL of 5% Methanol (MeOH), 0.1% TFA, in H2O
5. Eluting: 0.5 mL of 70% AcN, 0.1% TFA in H2O
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All C8 column supernatant eluates were dried under nitrogen (N2) flow. For the
EDTA supernatant we used 4 columns (100 mL per column), so the total elution volume
was 2 mL. For GuHCl supernatant we used 2 columns (100 mL per column), so the total
elution volume was 1 mL. We then pooled together both supernatants, for a total pooled
volume of 3 mL and dried down the eluate to ~ 0.25 mL in a 50-mL Falcon tube using a
flow of N2. The concentrated eluate was transferred to 2 vials and another 50-100 µL of
the elution solution was added to the tube in which they were dried in order to wash it
and retrieve the material that was still stuck on the walls of the tube. The C18 column
supernatant eluates were also dried under N2, but they were not combined as the C8
fractions.

UV Absorbance
The UV absorption (Wavescan 200-350 nm) of the sample’s C8 Eluate solution
was measured, using a 10 mm path length quartz cuvette, in the spectrophotometer
(NanoPhotometer). Proteins usually show absorbance at 280 nm, due to the presence of
the amino acids Phenylalanine (257 nm), Tyrosine (274 nm), and Tryptophan (280 nm)
by their characteristic absorbance (Freifelder 1982).

Total Protein Assay
We assayed the fossil sample eluates with BCA, which is a quantitative protein
assay, and determines the total amount of protein in the solution. We used bovine serum
albumin (BSA) as a standard and 96-well micro-plates for the assay. For better accuracy,
both the standards and samples were done in triplicate. Because the fossil samples were
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in limited amount, we used a miniaturized method for the BCA assay. Instead of using 50
μL of the fossil sample (considering that we only had 300 μL of it), we just used 1 μL (in
triplicate) and 4 μL (in triplicate) of each fossil sample, mixed with 51 or 48 μL of
diluent (H2O), and to that we added 50 μL of the BCA Working Reagent in each well.
The varied dilution concentrations were all taken into account in the calculations. As for
the standards, we used 50 µL of the Standard dilutions and 50 μL of the BCA Working
Reagent in each well. For controls (in triplicate) we used the 50 μL aliquots of the 0.5 M
EDTA solution, and 50 μL aliquots of the 6 M GuHCl solution, the Wash solution and
the Elution solution respectively. As a blank we used Milli-Q Water. After incubating the
plate with a plastic cover for over 2 hours at 37°C, we read the UV absorbance at
wavelength 562 nm (562 nm is in the visible range).

Fast Protein Liquid Chromatography
We used FPLC to sort by sizes the molecules in the elution solution of the fossil
samples. We took 150 μL of the concentrated eluate (which was dried down under N2),
then added 80 μL of the elution solution (blank) to fulfill the minimum volume required
for injection. The column used was a Superdex Peptide HR 10/30, with a flow rate of 0.5
mL/minute. The equilibration of the column was a ¼ column volume. The sample
injection volume was 100 μL. Eluent A was 30% AcN, 0.1% TFA. The fractions were
collected in low retention 1.5 mL vials in 0.5 mL aliquots in each.
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Matrix-Assisted Laser Desorption/Ionization-Time of Flight
We used MALDI-TOF to confirm the FPLC results regarding the sizes of the
molecules in the samples. We took 10 μL of the FPLC eluates and spotted over the spots
of the crystallized matrix on the MALDI plate. We also spotted just the matrix, for
comparison. Took readings of the major peaks shown in the FPLC results.

Liquid Chromatography Mass Spectrometry
From the FPLC elutions of sample BFW, we collected ~1 µg of protein and
placed them in 1.5 mL Eppendorf vials in 15 µL of 0.25% TFA. Samples were analyzed
by means of an autosampler, in the Thermo Scientific LCQ Ion-Trap Liquid
Chromatography Mass Spectrometer. We used a magic C18 capture column. The resulting
“.RAW” files were further analyzed with the software BioWorks, and the resulting
putative peptides indicated using the software PEAKS (a DE NOVO sequencing program
for interpreting MS/MS results).

Results and Discussion
Protein Extraction
Both EDTA and GuHCl solutions that were extracting the proteins from the fossil
samples were brown colored during incubation. After the C8 and C18 column protocols,
samples were free from salts, but the eluate remained of a yellowish color.
The C18 eluates of the fossil sample BFW EDTA fraction, after being centrifuged
at 6,000 rcf for ~1 minute in a 1.5 mL Eppendorf vial, was seen as being made of two
phases. The upper phase was clear and the lower phase was more of a yellowish color.
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This separation is seen in mixtures of hydrophilic with hydrophobic molecules, such as
mixing water with oil. The presence of oil in this particular extraction can be due to the
higher hidrophobicity of the column used – the C18 column, as compared to the C8
column. The lipid presence in the fossil samples is at least as intriguing as the presence of
original proteins in them.

UV Absorbance
Here we provide the UV absorption readings [Fig. 2.01] of both controls and
fossil samples. In doing the UV assay of the fossil sample BFW, we saw a small but yet
considerable absorbance around 260-280 nm.
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A. UV of Blank (just elution solution

B. UV of fossil whale bone (BFW)

70% AcN, 0.1% TFA)

D. UV of CONTROL (Chicken)

3.0

Absorbance (A)

Absorbance (A)

C. UV of CONTROL (Cow)

2.0
1.0
0.0
200.0

250.0

300.0

350.0

400.0

3.0
2.0
1.0
0.0
200.0 250.0 300.0 350.0 400.0

Wavelength (nm)

Wavelength (nm)

E. UV of fossil whale BONE (SP08-23b)

F. UV of SEDIMENT adjacent to fossil bone
(SP08-23sed)

Figure 2.01 – UV absorption of protein extractions – UV of (A) Just blank (70% AcN, 0.1% TFA),
(B) Fossil BFW, (C) Cow, (D) Chicken, Fossil sample SP08-23 (E) BONE, and (F) its surrounding
sediment.
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In the comparison of absorptions [Fig. 2.01] the fossil sample SP08-23 shows
greater absorption [E] than its immediately surrounding sediment [F]. Figures 2.02-2.10
are the UV readings of controls and fossils. Due to the large number of printouts, we are
only including the first result of each sample, with the EDTA and the GuHCl, but not
including the many dilutions performed.
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Figure 2.02 - UV absorption of Chicken EDTA (left) and GuHCl (right) eluates. Especially in the
EDTA fraction there is a prominent peak at around 280 nm, indicative of protein, due to the
characteristic absorbance in that region of aromatic amino acids.

Figure 2.03 - UV absorption of Cow EDTA (left) and GuHCl (right) eluates. The same prominent
peak at around 280 nm is shown here, which indicates the presence of protein.

Figure 2.04 - UV absorption of SB–Whale EDTA (left) and GuHCl (right) eluates. Peaks seen in the
cow and chicken controls around 280 nm are also seen here, but less prominently.
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Figure 2.05 - UV absorption of fossil sample BFW EDTA (left) and GuHCl (right) eluates. There is
some indication of a bend in the curve of the graph around 280 nm, but the implication of such a
small bend may be that there is very little protein in this fossil sample.

Figure 2.06 - UV absorption of fossil sample EFW EDTA (left) and GuHCl (right) eluates. UV
absorption apparently does not distinguish the presence of protein in the sample.

Figure 2.07 - UV absorption of fossil sample SP08-20 EDTA (left) and GuHCl (right) eluates.
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Figure 2.08 - UV absorption of fossil sample SP08-23-Bone EDTA (left) and GuHCl (right) eluates.

Figure 2.09 - UV absorption of fossil sample SP08-23-Sediment EDTA (left) and GuHCl (right)
eluates.

Figure 2.10 - UV absorption of fossil sample SP08-34 EDTA (left) and GuHCl (right) eluates.
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The UV absorbance of the fossil samples suggests the possibility that the
absorbing amino acids are present in the samples. It shows that there is greater
absorbance in the fossil bone than in its adjacent sediment (though this adjacent sediment
may have been composed of decaying flesh of the original whale). This seems to indicate
that the fossil bone may have protected its original proteinaceous content better than the
sediment or soft tissues around it did (such as flesh, baleen, skin, etc.).
When we take into consideration the results of the UV, BCA, and Microscopy,
not all samples appear to be very promising as far as protein presence, but a few samples
provide encouraging results. We decided to work mostly on sample BFW because it
showed promising results in all assays performed.

Total Protein Assay
The total protein results of the Controls (Cow, Chicken and Whale) elutions are
shown in figure 2.11.
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Figure 2.11 – BCA readings of control samples. Protein yields per gram of sample of the controls, as
measured by the Micro BCA assay.
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After testing the standards, we proceeded to assay the fossil samples. They
showed a much smaller absorbance, relative to the standards. However, if we increased
the initial amount of fossil sample, the protein content rapidly reached the higher
concentrations seen in the controls.
The total protein (average of the combined supernatants) of the fossil samples is
shown in figure 2.12.
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Figure 2.12 – BCA readings of fossil samples. Average protein yields per gram of Fossil samples

From these graphs we see that the amount of protein indicated by the BCA assay
as being present in the fossil samples vary, but all samples have an overall higher protein
amount than the fossil sediment sample (even though the sediment sample was taken
from a region right adjacent to the bone sample ~ 0.5 cm away from the edge of the
bone).
Therefore the BCA results confirm what the UV absorption results indicated: that
small, but yet, detectable amounts of proteinaceous materials are present in the fossil
samples.

Fast Protein Liquid Chromatography
The fossil sample BFW that was analyzed through FPLC gave indication of the
presence of peptides in the sample solution. The peaks were right where they were
expected in a control sample peptide graph. The result is shown in Figure 2.13.
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FPLC of sample BFW C8 elution of EDTA + GuHCl combined
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Figure 2.13 - FPLC chromatogram of fossil sample BFW. The C8 elution fractions of EDTA and GuHCl
were combined in order that the signal would be stronger. Vials A1-C13 are where the FPLC elution
solution was collected for further analysis.

Based on this chromatogram and the data obtained from the UV and BCA assays,
we may deduce that there are small sized but yet abundant putative peptidic materials in
the sample. The majority of it is smaller than 2,000 Daltons, and there appears to be
discrete peaks, which may suggest that the peptides vary considerably in size. However
there is enough relative abundance of each type or cluster of peptides that individual
peaks can be distinguished in the FPLC output.
If the sample had anything larger than 7,000 Daltons, it would come out and be
chromatographed around vials A4 and A5. That’s where the large molecular weight
material should appear. When we take a close-up look [Fig. 2.14] at that region by
enlarging it vertically (notice the scale on the left side), we see that there is a small, but
not random, peak at the end of the void volume.
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Close-up of FPLC of sample BFW C8 elution of EDTA + GuHCl combined
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Figure 2.14 – FPLC chromatogram of fossil sample BFW showing early peak. The EDTA and GuHCl
supernatants were combined in order to improve the protein signal. In the close-up, the smaller peaks can
be seen, such as the peak between A4 and A7 labeled “A” pointed out by the arrow. It might reflect the
presence of the higher molecular weight materials such as Osteocalcin, some larger collagen fragments, or
some unknown protein fragment. Vials A1-C13 are where the FPLC elution solution was collected for
further analysis.

This peak appears between fractions A5–A6. It may reflect the presence of
Osteocalcin in the fossil extract or at least some larger molecular weight protein
fragments. The relatively large peaks in the regions from B1–C10, are possibly due to
peptides of various sizes. The putative peptidic presence is in agreement with the BCA
assay results. We pooled fractions A4-A8 and labeled it “A”, B8-B11 labeled “B”, B12B14 labeled “C”, and B15-C3 labeled “D”. These fractions are later brought up again in
the MALDI-TOF section. The following figure [Fig. 2.15] indicates which fractions
correspond to which labels.
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Figure 2.15 – Combined fractions of FPLC of sample BFW. Chromatogram of combined EDTA and
GuHCl elutions. Letters A-D indicate the fractions that were pooled together in order to proceed to the
MALDI-TOF mass spectrometry analysis of this sample. Vials A1-C13 are where the FPLC elution solution
was collected for further analysis.

The fractions that were eluted from the FPLC were combined as shown in Figure
2.15, and were afterward dried down in order to concentrate them. These letters (A-D)
correspond to samples later spotted in the MALDI-TOF plate and assayed.
Both the previously described BFW extraction and also an earlier extraction
(Figure 2.16) show a similar peak in the beginning of the chromatogram, after the void
volume. This peak may correspond to larger peptides or almost complete small proteins.
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Figure 2.16 – Previous FPLC chromatogram exhibiting early peak. This peak may indicate the presence of
higher molecular weight materials in the fossil sample. Vials A1-C13 are where the FPLC elution solution
was collected for further analysis.

There is clearly much less material in the region where osteocalcin or some larger
protein fragments would be than in the region where smaller peptides would be. This
could mean that the majority of the molecules present in the fossil sample extract are very
fragmented, but that there is a small presence of the higher molecular weight material.
More on this will be discussed in the MALDI-TOF section.
After we had worked with the fossil, we decided to look at the pattern of extant
whale protein extract in the FPLC as controls. We realize that the protein profile
chromatographed in the FPLC results, and for that matter in any other types of
experiments, may show great variance between the fossil and the extant samples because
of the numberless factors that may contribute to, or even prevent, protein breakdown.
As for the extant whale control run, the FPLC result is shown in Figure 2.17.
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Figure 2.17 - FPLC of an extant whale sample. Vials A1-C13 are where the FPLC elution solution was collected for further
analysis.

The modern whale doesn’t show the individual peaks seen in the fossil’s output.
This could be because there are too many different protein fragments in this sample, of
multiple sizes, which don’t show as individual discrete peaks, but as a large single peak.

Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight
The MALDI-TOF results were very helpful in determining the sizes of the
materials present in the sample; more than any other type of experiment we had done
before. These peaks are in size agreement with the peaks shown in the FPLC results. The
fossil extract resulted in peaks of higher molecular weight than the peaks found only in
the matrix blank (the matrix blank was only a matrix spot, without the addition of the
sample). The right side of the following figures (Figures 2.18-22) presents the spectrum
with peaks from the matrix blank and from the fossil sample BFW. These peaks are
plotted by size (x-axis) vs. abundance (y-axis). On the left side, the masses (m/z) of the
major peaks are listed. Figure 2.18 shows the matrix blank spectrum.
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Figure 2.18 - MALDI-TOF of Matrix (Blank) – Only the MALDI matrix used in assisting sample ionization
was spotted.

The peaks shown in the matrix blank are related to the sizes of the materials
present in the matrix. The largest peaks range up to ~909 Daltons.
Now compare this to the fossil peaks shown in Figures 2.19-2.22. The fossil
sample’s spectrum indicates the presence of some extra peaks corresponding to higher
molecular weight materials, aside from those present only in the matrix.
The fossil samples shown in Figures 2.19-2.22 are the ones that were subjected to
FPLC, which fractions were pooled together (see the FPLC section).
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Figure 2.19 - MALDI-TOF of FPLC Fraction “C” spotting 4 of fossil sample BFW.
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Figure 2.20 - MALDI-TOF of FPLC Fraction “C” spotting 5 of fossil sample BFW.
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Figure 2.21 - MALDI-TOF of FPLC Fraction “D”, spotting 1 of fossil sample BFW.
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Figure 2.22 - MALDI-TOF of FPLC Fraction “D” spotting 3 of fossil sample BFW.

The peaks shown in the MALDI-TOF output, which were not present in the
matrix include: 927, 1033, 1052, 1077, 1096, 1106, 1161, 1287, 1310, 1349, 1498, and
1538 Daltons. These exclude anything below the 908 Daltons, which corresponded to the
largest molecular weight peak shown in the matrix blank.

Liquid Chromatography Mass Spectrometry
The overall fragmentation pattern obtained both from the standard used (BSA),
and from the fossil sample BFW are shown here. When the BSA fragmentation pattern
was compared to the protein database (Mascot, from Matrix Science), there were over 7
protein hits, with dozens of matching sequences. The search was performed by selecting
trypsin as the enzyme responsible for the digestion of the BSA protein.
In the analysis of the fossil, we realized we did not have an option of choosing
“no enzyme” in the search, although the fossil was fragmented, not by means of a
specific enzyme, but by means of unknown processes, of which we have no knowledge.
When we performed the search, there were absolutely no significant hits, with zero
matching sequences to anything. This makes sense because the search was looking for
trypsin digested peptides. This is evidence that there was no cross contamination between
the standard and the sample. The implication is that DE NOVO sequencing should only
find fossil material and not any contamination from the BSA standard.
Figure 2.23 shows the graphs of the BSA standard fragmentation pattern. Figure
2.24 shows the BSA standard sequence matches by Mascot search against the SwissProt
database.
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Figure 2.23 - LC/MS of BSA standard. The top part represents the full MS pattern, whereas the bottom
section represents the fragmentary MS/MS pattern. The peaks from around 70 minutes up unto 100
minutes are characteristic of peptides.

Figure 2.24 – BSA standard peptide fragmentation match in Mascot. LC/MS matching sequences of
BSA in Mascot search when compared to the SwissProt database. BSA standard was digested with
trypsin enzyme. There were 7 significant protein hits and dozens of matching sequences.
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Figure 2.24 – Continued.
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The fossil sample BFW had no significant protein hits when compared
against the SwissProt database (Fig. 2.26). In the search, trypsin was specified as the
digestive enzyme. If there were trypsin digested peptide hits in the fossil sample, it could
be suggested that it was a contamination from the BSA standard. However, because we
did not use any enzyme in digesting the fossil material, the absence of trypsin pattern hits
supports the idea of non-contamination of the sample with the standard. Nevertheless,
even though there were no hits for trypsin digested peptides, BFW displayed secondary
(MS/MS) fragmentation (Fig. 2.25) in the place where they should appear in an extant
sample. This suggests that BFW contains peptides (not from trypsin) that can be original
(from whale), or at least from the sample (whether whale or bacterial, but not from
machine contamination). Since we were not able to locate a whale database to compare
them to, DE NOVO sequencing seems to be the next required procedure, in order to
determine the identity of these peptides.
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Figure 2.25 - LC/MS of fossil sample BFW. The upper portion represents the full MS pattern, and the
lower portion represents the MS/MS fragmentation pattern. In the same region that peptides appear in
non-fossil sample, there is positive signal in the fossil sample. The fragmentation pattern in the lower
portion is only due to peptides. If the peaks in fact correspond to peptides, then there are a number of
them still present in the sample.

Figure 2.26 – Fossil BFW peptide fragmentation match in Mascot – The fossil sample BFW
showed no significant hits, when compared to a database that looked for trypsin digested
peptidic material. This supports the non-contamination approach used throughout all the
course of this study. Because no trypsin was used to digest the fossil sample, trypsin peptides
should not appear, except if there was cross-contamination with standards.
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The fragmentation pattern of the fossil is evident in the same region where it
usually appears when extant proteins are analyzed. This is very important in determining
the nature of the material from fossil BFW analyzed through all the previous experiments
and assays. They seem to be suggestive of peptidic material and behave as that. This
assay was a further confirmation of the previous steps in the analysis of this fossil
sample.
To determine which peptides or sequences they specifically represent will require
further research.

Conclusion
The fossil whales of the Pisco Formation are indeed of import, not only from an
inorganic, sedimentary perspective, but also from the organic, molecular, and
ultrastructural perspective. In addition to the preservation derived from still articulated
bones and the presence of fossil baleen in life position, the results of the experiments also
suggest a certain level of biomolecular preservation.
There is proteinaceous material in the samples, but the level of it varied.
Nevertheless, it is worth of notice that when fossil sediment was compared to fossil bone,
even though the sediment sample was located immediately adjacent to the fossil bone, it
presented an average protein concentration below that presented by all fossil bones
analyzed, including those badly preserved, implying that the fossil bone provided a better
environment for biomolecular preservation than its surroundings. Detection of preserved
proteinaceous material from the fossil bone samples is supported by the BCA assay, the
TLC analysis, the FPLC profile, the MALDI-TOF mass spectra, and the LC/MS
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fragmentation pattern (characteristically observed with peptides). In addition to extracted
proteinaceous material, we were also able to extract a considerable amount of lipids from
the fossil samples. This is consistent with a number of reported lipid findings in fossil
samples (Das et al. 1967; Mackenzie et al. 1982; Eglinton et al. 1991; Briggs et al. 2000).
The presence of proteinaceous material (and possibly of lipids) suggests that these fossil
whales are highly preserved, even down to the biochemical level; this unexpected
preservation is now further indicated by reasonable experimentation.
Because of the altered nature of animal remains found in the fossil record, they
are far more complex to analyze than extant samples. There is the potential for
unexplained changes to happen. Even though we can do repeated experiments, it is not
with absolute certainty that conclusions can be drawn. Nevertheless, some conclusion
may prove of value.
Unlike the samples that Schweitzer reported from T-rex, with still soft and pliable
original tissue (Schweitzer et al. 2005), our samples, after partial demineralization
remained brittle, implying that much of the organic material had been replaced by
mineral components. In spite of that, we still observed evidence of proteinaceous, as well
as lipid material.
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CHAPTER THREE
MATERIALS AND METHODS

In this section we describe the methods used in this study in search for ancient
biomolecules. We went from general to very specific assays: light microscopy, and then,
Scanning Electron Microscopy for more detail. After that, we used biochemical methods
to describe the search for biomolecules. The methods we used are listed below.
1. Light Microscopy of samples in order to have a better understanding of the degree of
the visual preservation of the samples.
2. Scanning Electron Microscopy of partially demineralized fossil samples, in order to
verify the level of ultrastructural preservation.
3. Ultra-violet analysis of the absorbance values consistent with aromatic amino acids.
4. Micro-Bicinchoninic acid Assay was employed in order to determine the protein
concentration of the sample extracts.
5. Fast Protein Liquid Chromatography, enabled improved resolution of protein and
peptide fragments from sample extracts.
6. Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry,
for determination of peptide molecular weights.
7. Dansylation of amino acids and Thin-Layer Chromatography, to see the amino acid
distribution of the samples, and confirm the results from BCA, FPLC and MALDITOF, supporting peptide and amino acid presence in sample extracts.
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8. Liquid Chromatography Mass Spectrometry, which is potentially able to give
putative peptide sequences based on MS/MS of Collision-induced dissociation (CID).

General Sample Preparation
Each sample was initially demineralized with 0.5 M EDTA
(ethylenediaminetetraacetic acid, pH 8.0, 0.22 m filtered). The EDTA acts as a chelating
agent, which “sequesters” metal ions such as Ca2+ and Fe2+, breaking the structure of
minerals, and allowing proteins to be released into the aqueous solution. Although many
proteins are water soluble, there are some, like the scleroprotein collagen, that are
generally hydrophobic, and tend to aggregate together. These proteins need to be
denatured in order to go into solution. In order for that to happen, we used a 6 M solution
of the strong denaturing agent Guanidine-HCl (GuHCl, pH 7.4, 0.22 m filtered). The
procedure we used was adapted from Schweitzer (2007a).
For microscopy experiments, only EDTA-dependent demineralization was
performed. For all other experiments the demineralization step was followed by the
protein denaturation step with GuHCl.
For positive controls we had: cow and chicken (both obtained from a local
market), extant whale (obtained from Raul Esperante) and a 20-year after death
weathered whale jawbone (a Santa Barbara Museum of Natural History, CA, specimen
provided to us by Paul Collins [pcollins@sbnature2.org], who serves as the curator for
the Museum).
Fossil samples included whale bones and sediment samples from the Pisco
Formation, Peru. Most of the analyses involved the sample labeled “BFW”. This sample
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was part of a rib from a fossilized baleen whale, cf. Balaenopteridae, found at GPS
location 18 L 8411328/422633 (datum South American ’69), which is in the upper,
diatom-rich, part of the Miocene/Pliocene Pisco Formation in Peru. The sample was
originally collected by Leonard Brand, from Loma Linda University, CA, and bore the
field label: “CBa-1 Whale #20, W20-99-015”.

Light Microscopy
About 1 g of the sample “BFW” was crushed into small pieces (1 mm2 or less)
with a steel mortar and pestle and subjected to demineralization using 10-20 ml of 0.5 M
EDTA, pH 8.0, for 3-5 days in a Petri dish, without shaking (to prevent damage to fragile
structures in the samples by movement). After partial demineralization, visible changes
were observed and water was substituted for the EDTA in order to stop further
demineralization. Samples were surveyed using a stereoscope (Bausch and Lomb Stereo
Zoom inspection scope, Rochester, NY) with a magnification of 0.7–3.0 X.

Scanning Electron Microscopy
Following initial work with light microscopy, further analysis was pursued with
the SEM for added detail. We began another demineralization procedure, which lasted for
about 5 days. When demineralization seemed to effect no more visible changes in the
sample, we stopped it by introducing water and removing the EDTA solution from the
Petri dish. The partially demineralized bone fragments were collected from the Petri dish
and transferred to the SEM’s specimen holder using an adapted 200 l pipette tip which
had the foremost part of the tip severed, so that the opening would be large enough,
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reducing physical damage to the fragile demineralized structures, as they were sucked up
the tip while being transferred. All specimens were Au/Pd coated for 60 seconds and
then placed in the SEM (Tescam) for analysis in vacuum.

X-ray Diffraction
About 2 g of sample BFW was demineralized with 0.5 M EDTA, pH 8.0, for 2-5
days. When no further noticeable demineralization was happening, we collected the
vessel-like structures that remained on the Petri dish and subjected them to XRD.

Biomolecules Extraction
We performed multiple extractions of proteins from the fossils. At first, we started
with a relatively small amount of fossil bone (~2 g), but kept increasing it, as we better
understood the protein concentration present in the samples. We surveyed an array of
fossil bones in order to determine the most adequate sample for conducting further
experiments. We experimented with dialyzing in order to retrieve the proteins from the
demineralization solution, but opted for another method. One that seemed to be more
straightforward, and less labor demanding – C8 spin columns.

Protein Extraction of 2-gram Samples
The initial amount used for a general survey was about 2 g of each of the 10 fossil
samples. All samples were frozen with liquid nitrogen, and ground to powder using a
steel mortar and pestle. The powdered material was demineralized with 10 ml of 0.5 M
EDTA overnight, and centrifuged (3,340 G). The supernatant was collected (Sup 1). Then
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another aliquot of 10 ml of 0.5 M EDTA was added to the pellet and incubated with
shaking for 3 days. The sample was centrifuged again and the supernatant was collected
(Sup 2). Then 5 ml of 6 M GuHCl was added to the pellet, and incubated at 60 °C
overnight. The sample was centrifuged and the supernatant collected (Sup 3). We
collected the proteins using the C8 SPE columns (Fisher), and eluted them in 70% AcN,
0.1% TFA. We proceeded to assay the eluates with UV absorption and to measure protein
signal by means of the BCA assay, as will be described below. Separately we performed
tests on extant control bones of cow, chicken and whale.

Protein Extraction of 20-gram Samples
Another extraction was done using a larger amount of the bone samples (~20 g).
Samples were frozen with liquid nitrogen, and ground to powder using a steel mortar and
pestle. As in the previous extraction, the powdered material was demineralized with 100
ml of 0.5 M EDTA overnight, centrifuged (3,340 G), and the supernatant collected
(Sup 1). Then another aliquot of 100 ml of 0.5 M EDTA was added to the pellet and
incubated with shaking for 3 days. The sample was centrifuged again and the supernatant
was collected (Sup 2). Then 50 ml of 6 M GuHCl was added to the pellet, and incubated
at 60 °C overnight. The sample was centrifuged and the supernatant collected (Sup 3).
Instead of using C8 Spin columns, we dialyzed the supernatants against nano-pure water
using a 2000 M.W. cutoff membrane for 3 days, changing the water 3–5 times at 4°C (in
a 4 L container). The contents were transferred to several tubes and frozen (-20°C or
-80°C). The tube lids were removed and the tubes were closed with parafilm. Holes were
poked in the parafilm in order that the water may be sublimated through them, and the

62

contents were lyophilized (trap temperature -50 °C, pressure 7–10 P) for several days
until dryness. The lyophilized material was taken and assayed with the same steps that
were followed after the C8 chromatography.

Protein Extraction of a 55-gram Sample
Finally, once we knew, from the previous results, which sample probably had the
highest protein preservation (sample BFW), we used up what we could of this sample in a
final extraction (~55 g). This time we did not freeze the samples prior to powdering, and
the results were still the same. The sample was ground to powder using a steel mortar and
pestle. But in contrast to the previous extraction, we only used 1 EDTA extraction (2
days), and one GuHCl extraction (20 hours). To the 55 g of powdered material we added
400 ml of 0.5 M EDTA, and incubated at room temperature for 2 days with shaking.
Then we centrifuged it at 6000 G for 1 hour, and collected the supernatant. Then we
incubated it with 200 ml of 6 M GuHCl for 20 hours at 60 °C with shaking. We
centrifuged it again at 6000 G for 1 hour and collected the supernatants, which were then
put through C8 extraction columns. These supernatants were then analyzed with more
extensive experiments than all prior samples, except the controls. These steps are
summarized in Figure 3.01.
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Figure 3.01 – Summary diagram illustrating C8 column procedure for protein extraction. (1) Both salts
(green) and proteins (yellow) are together in the solution, but we want to get rid of salts and keep the
proteins. The solution is put through the C8 column. (2) Salts are flowed through, and the proteins are
retained. (3) Proteins are finally eluted from the column and saved.

Protein Capture by C8 Solid-Phase Extraction Columns
Proteins from the supernatants were first captured using the PrepSep C8 SolidPhase Extraction Columns (C8 PrepSep Extraction Columns, Fisher Scientific, Fair
Lawn, NJ, 07410, Cat. # P452, Lot # 076082), also referred to as “spin columns”,
according to the following protocol:


To the column, we added 3 ml of wet solution: 100 % AcN and centrifuged it for
1 minute. Discarded the flowthrough.



Added 3 ml of equilibrate solution: 0.1 % TFA and centrifuged it for 1 minute.
Discarded the flowthrough.



Flowed the whole supernatant through the column. Saved the flowthrough.



Added 12 ml of wash solution: 0.1 % TFA, 5 % MeOH and centrifuged for 2
minutes. Discarded the flowthrough.



Added 0.5 ml of elute solution: 70 % AcN, 0.1 % TFA. Centrifuged for 1 minute.
Saved the eluate.

Protein Capture by C18 Solid-Phase Extraction Columns
Following the C8 extraction, we decided to capture everything we could of
proteins/peptides from the supernatants that flowed through (the “flowthroughs”) of the
C8 spin columns. So we decided to use the C18 extraction columns (Ultra-Clean SPE C18
200 mg/4 ml, Grace Davison Discovery Science, Deerfield, IL, 60015, Cat. # 505150,
Lot # 50295282), for their higher affinity to non-polar molecules:


To the column, we added 3 ml of wet solution: 100 % AcN and centrifuged it for
1 minute. Discarded the flowthrough.
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Added 3 ml of equilibrate solution: 0.1 % TFA and centrifuged it for 1 minute.
Discarded the flowthrough.



Flowed the whole supernatant through the column. Saved the flowthrough.



Added 12 ml of wash solution: 0.1 % TFA, 5 % MeOH and centrifuged for 2
minutes. Discarded the flowthrough.



Added 0.5 ml of elution solution: 70 % AcN, 0.1 % TFA. Centrifuged for 1
minute. Saved the eluate.
Therefore, we collected everything we thought possible to collect. In one of the

column elutions (the C18 elution from the BFW EDTA fraction), after we centrifuged the
eluate, we were surprised to see that the liquid inside the vial was composed of two
phases! There was a clear part (the upper), which was divided by a distinct line from the
more yellow colored line (the lower). This could indicate that the sample still contains
lipids, which were captured by the C18 column. The reason we had never seen this before
is that we had never used the C18 columns before to capture materials from the BFW
demineralizing fractions. For most of the experimentation time we had only used C8
columns, which are less hydrophobic than the C18, and therefore, less able to capture
lipids than the C18 columns.

UV Absorbance
The UV absorption (Wavescan 200-350 nm) of the sample’s C8 Eluate solution
was measured, using a 10 mm path length quartz cuvette, in the spectrophotometer
(NanoPhotometer). Proteins usually show absorbance at 280 nm, due to the presence of
the amino acids Phenylalanine (257 nm), Tyrosine (274 nm), and Tryptophan (280 nm)
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by their characteristic absorbance (Freifelder 1982). We took repeated measurements of
each sample, with several dilutions of each, but we report the most prominent results of
each sample.

Bicinchoninic Acid Assay
Because UV absorbance can also be due to DNA, or other unknown factors, and
not just to protein presence, we performed more specific tests in order to better determine
the nature of the material preserved.
We assayed the fossil sample eluates with BCA to determine the total level of
protein in the solution. We used BSA as the standard, and the 96-well Polystyrene assay
microplate (Corning, Lowell, MA) for assay preparation, incubation, and reading. We
assayed both samples and standards in triplicate. We used 75 µL of the BCA Working
Reagent (prepared using 25 parts of solution A, 24 parts of B and 1 part of C) and 75 µL
of sample or standard or blank on each well. After incubating the plate with a plastic
covering for at least 2 hours at 37 °C, we read the UV absorbance at wavelength 562 nm
in a µQuant machine (Bio-Tek Instruments, Inc. Winooski, VT).

Gels
SDS-PAGE gel assays of both the controls and fossils were performed. In the
protocol used, aliquots of the samples were dissolved in HEPES buffer (20 mM HEPES,
150 mM NaCl), and transferred to 1.5 ml vials. To the vials was added NuPAGE LDS
Sample (Bromophenyl blue). Then the vials were heated for 5 minutes at 88°C, their
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content was transferred to the gel wells and run. The gels used were 4-12% SDS-PAGE
(Gradient NuPAGE 4-12% Bis-Tris-Gel).
Samples were subjected to 2 different staining methods: Coomassie Blue and
Silver stains. The Coomassie Blue comes in a solution already prepared. We added that
solution to a container and placed the gel in it. We put the container in a shaker, and left
it staining for over 2 hours.
The silver stain method requires considerably more effort, and it is not as straight
forward to apply as the Coomassie Blue stain, but it is more sensitive, and therefore, can
detect lower amounts of protein. The protocol for silver staining is described below:

Silver Stain Protocol (Mass Spectrometry Compatible)
Protocol obtained from http://proteomics.missouri.edu/protocols/proteinDetection.html,
accessed in June 10, 2010, at 9:35 AM, UTC/GMT -8 hours.
1. Fix gel in 100 mL of 20% ethanol, 1% acetic acid for 1 hr.
2. Wash gel in 20% ethanol for 10 min.
3. Pre-treat gel with 100 mL 0.02% sodium thiosulfate for 1 min.
4. Decant and rinse gel in Milli-Q water for 1 min.
5. Add 100 mL of 0.1% silver nitrate solution and agitate for 15-20 min.
6. Decant and rinse gel in Milli-Q water for 1 min.
7. Decant and add 100 mL of developing solution (2% sodium carbonate, 40 mL
37% formaldehyde). Develop until protein spots are visible (5-10 min).
8. Stop developing with 5% acetic acid (5-10 min) and replace with Milli-Q water.
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After removing the gel from the solution, we inspected the gel surveying it for
any visible bands.

Fast Protein Liquid Chromatography
The initial preparation of the fossil sample “BFW” for FPLC and MALDI-TOF is
described in the “Protein Extractions” section. The specific amount used from the fossil
sample was 55 g. EDTA and GuHCl extraction supernatants were put through the C8
Spin column and eluted in 0.5 ml of the elution solution. There were 4 columns for the
EDTA and 2 columns for the GuHCl, so that the combined elution volume was 2 ml from
the EDTA extraction and 1 ml from the GuHCl extraction (a total of 3 ml).
These 3 ml were combined and divided into two 50-ml falcon tubes, in order to
concentrate them under a laminar flow of nitrogen. They were concentrated from 1.5 ml
down to about 200 µl on each tube, and then transferred to 1.5 ml Eppendorf vials. After
the transfer, we added 100 µl of the elution solution (used in this case as a re-suspension
solution) to each of the 50-ml tubes in order to retrieve, as much as possible, the
molecules that might have been stuck to the walls (concentrating the sample decreases its
solubility). After shaking them well, we transferred the 100 µl suspension solutions to the
contents already in the Eppendorf vials. The total volume in each vial reached about 300
µl of concentrated sample (fossil stock).
We took 1 of these vials and dried it down still further to 150 µl. Then we assayed
the sample with FPLC using a Superdex Peptide HR 10/30 column, at a flow rate of 0.5
ml/minute, with buffer of 30% AcN, 0.1% TFA. We used 2 column volumes for
replacing the column’s storage medium and ¼ column volume before each sample for
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equilibration of the column (with 5 ml of void volume and another 5 ml of equilibration).
The best resolution of this type of column is for molecules whose weight ranges from
7,000-300 Daltons.
This type of column is especially useful for peptidic analysis, and anything above
7000 Daltons will likely flow through first as a peak early in the elution, along with the
injection front, right after the excluded volume (around 6.25 ml).
In preparing the sample to be put through the column, we realized we needed over
200 µl in order to have a full 100 µl injected in the column, but we had dried it down to
150 µl already. So we added 80 µl of the running buffer to the sample vial, shook well,
and centrifuged that vial at 11,000 G for 10 minutes in order to get rid of any particular
matter. We then injected 100 µl of the sample in the column.
The FPLC fractions were eluted in 0.5 mL aliquots into 1.5 mL Eppendorf vials
and were afterward dried down in the speed vac. The concentrated solutions were spotted
onto the MALDI-TOF plate for mass spectrometry.
The settings used for the FPLC column procedure are shown in Figure 3.02.
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Figure 3.02 – FPLC settings printout – Settings used in the protocol used in the FPLC analysis
of the fossil sample BFW.
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Besides the fossil, we used a protein extraction from an extant whale, extracted in
the same manner as the fossil. In order to use the same peptide column, which was used
for the fossil, we decided to use a filter membrane that would remove anything larger
than 30,000 Daltons, so that no excessively large peaks would appear in the beginning of
the chromatogram. We just wanted to see what peptides were present in the extant whale,
without the necessity of digesting its proteins. We put the filtrate through the FPLC
column and chromatographed it using the same settings described earlier in the fossil
procedure. Then we took aliquots from a few of these fractions and spotted them on
MALDI-TOF to see their profile.

Matrix-Assisted Laser Desorption/Ionization-Time of Flight
In order to determine the sizes of the molecules in the protein extract, we
proceeded to assay it with MALDI-TOF. We took the C8 spin column EDTA 1, EDTA 2,
and GuHCl eluates, some which were and some which were not put through FPLC, and
spotted them in the MALDI plate. Again we will not show all the data collected, because
there were many readings (which can be found in the lab books), but we will show the
most relevant ones. The protocol used was the following:

MALDI-TOF Protocol
1. Wash plate and dry
2. Deposit 0.5 l of 50 mM ammonium bicarbonate
3. Place on hot plate for 10 seconds
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4. Deposit 0.5 l of matrix solution (HCCA [α-Cyano-4-hydroxycinnamic acid], SA
[sinapinic acid] or DHB [2,5-dihydroxybenzoic acid])
5. Place on hot plate for 10 seconds
6. Deposit 0.5 l of sample solution
7. Place on hot plate for 10 seconds and analyze
A variation of this protocol was also used, skipping steps 2 and 3. Both linear and
reflected TOF were used. Besides the fossil, we also assayed cow, chicken and whale as
controls.

Dansylation and Thin-Layer Chromatography
In order to have a better appreciation of the nature of the material indicated in the
FPLC and MALDI-TOF outputs, we assayed the samples with Polyamide TLC. This aids
in confirming the proteinaceous properties of the sample extracts, resolved by FPLC or
MALDI-TOF into distinct peaks. In this assay, the amino acids are dansylated and
migrate through the thin-layer plate carried by the solvent phase (hydrophilic or
hydrophobic). The solvents are “run” in 2 dimensions, with the first dimension using a
hydrophilic solvent, and the second dimension employing a hydrophobic one. Because
the dansyl label is highly fluorescent under UV light, even a low amount of amino acids
(a few nmols) is enough for detection through this method. Furthermore, the amino acids
travel at certain distances in the plate. The relative position of the spots in the TLC plate
can be correlated with the traveled distances of amino acid standards.
The method we used was adapted from Low et al. (1980) and Van Buskirk et al.
(1980). We made a few changes to the methods used by these researchers because some
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of the new resources available today for assays may not have been available 30 years ago.
One of the changes was from Porapak to C18 Extraction columns. We experimented with
both columns, and the C18 column gave a much better result than the Porapak (see
comparison of C18 vs. Porapak below).
As standards we used glutamic acid (Sigma, Cat. # G1251, Batch # 079K01021),
-carboxyglutamic acid (also known as “Gla”, from Sigma, Cat. # C4147, Batch
# 089K1177), and Osteocalcin (bovine, MP-Biomedicals, Solon, OH 44139, Cat. #
194940 Lot # 9378j), as well as the blanks (DNS-Cl blank and Elution solution blank).
The DNS-Cl was from Invitrogen, Cat. # D21, Lot # 513354. Below is the step-by-step
outline used in the adapted method.
For the Glu and Gla standards, we skipped the hydrolysis steps because they were
individual amino acids. We prepared a 10 mM Glu or a 20 mM Gla solution in 100 mM
NaHCO3 respectively, and stored each at -20°C. From the stock solution we took the
equivalent volume containing ~1 nmol of each amino acid standard for labeling with a
dansyl fluorophore.
Since acid hydrolysis also hydrolyses the extra carboxyl group in the  position of
the Gla amino acid R group, we had to use alkaline hydrolysis for the osteocalcin and for
the fossil material. The hydrolysis vial was a 5 ml Reacti-vial Small Reaction Vials
(Thermo Scientific, Rockford, IL, 61101, Prod. # TS–13223, Lot # LA12718830), with a
Miniert valve (Thermo Scientific, Prod. # TS–10135). We pipetted into it, 100 l of 2 M
NaOH and 1 l of a 10 g/l Osteocalcin solution (~1.7 nmol). We then removed O2
from the Reacti-vial by introducing nitrogen gas into it, and letting it run for 3 minutes.
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The vials were then incubated at 108°C for 22 h. After hydrolysis, we neutralized it to pH
7.5 and made it to 100 mM NaHCO3.
Standards or fossil solutions were mixed with equal volumes of 750 µg/ml DNSCl in acetone, and incubated 4 hours in the dark. Then the solutions were dried down in
the speed vac to remove acetone. Then these were dissolved with 500-1000 µl 0.1% TFA
in water. These preparations were then applied to the C18 extraction columns (UltraClean SPE C18 200 mg/4 ml, Grace Davison Discovery Science, Deerfield, IL, 60015,
Cat. # 505150, Lot # 50295282). Free amino acids were adsorbed to these C18 columns,
The columns were employed using the following amino acid retrieval protocol:
wetted the column with 3 ml of 100% EtOH, equilibrated the column with 3 ml of 100
mM HCl, then put the sample through the column (saved apart the flowthrough), washed
the column with 12 ml of 100 mM HAc in order to remove the salts, eluted the sample
from the column with 0.5 ml of a solution of acetone, EtOH, water (4:5:1).
The eluates were evaporated to dryness and redisolved in 10 µl of EtOH. The
samples were spotted on the Polyamide TLC plates. Used 20 cm square polyamide sheets
(Polyamide-6 sheets TLC plates, polyester backed, thickness 100 µm, Sorbent
Technologies, Atlanta, GA 30366, Cat. # 3522026, Lot # 010113K). Figure 3.03 shows
the Polyamide sheet solvent and spotting layout.
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Figure 3.03 - Polyamide sheet solvent and spotting layout.
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Added 0.5 l aliquots of sample at the spot origin (2 cm from each edge of the
polyamide sheet), let it dry, repeated spotting until all 10 l were applied to the sheet, and
spotted several combinations in different plates: DNS-Cl blank, elution solution blank,
just Gla, just Glu, Gla+Glu, Osteocalcin, and Fossil.
In the first running dimension we used the polar solvent: 100 ml of 1.35% formic
acid, and placed the plates in the TLC chamber, which had the solvent and closed the
chamber with its lid. Then we let the solvent run up the plate for 4-5 hours, removed the
plates from the chamber, let them dry and imaged them. We then removed from the
chamber the first dimension’s solvent and added to it the second dimension’s solvent:
100 ml of n-heptane, n-butanol, glacial acetic acid (3:3:1). We placed the plates in the
chamber and let the solvent run up the plates for 2.5 hours, removed the plates from
chamber, let them dry and imaged them.

C18 vs. Porapak Columns
Which method is better for separation the DNS-amino acids (any amino acid)
from the DNS-hydroxide (which is not linked with any amino acids)? We tested 4
methods or combinations using the Glutamate (Glu) standards. After Glu had been
dansylated, we took the equivalent volume of 100 nmols of Glu for testing each method.
We used 2 C18 columns and 2 Porapak columns. For the first C18 column we used the
protein retrieval protocol: wetted with 3 ml of 100% AcN, equilibrated with 3 ml of
0.1% TFA, then the sample was put through. It was further washed with 12 ml of 5%
MeOH, and eluted in 0.5 ml of 70% AcN. On the second C18, we used the standard amino

77

acid retrieval protocol described in the previous pages. For the Porapak columns we also
used the standard amino acid retrieval protocol.
The elution of each of the columns was dried and taken up in 10 l of EtOH. We
put 9 spots in each sheet (duplicated the same setup for each sheet): 1 spot in the center of
the lower part of the plate from a DNS-Cl blank, that had not been put through the
column served as a control, then one from the C18 eluate, which had been processed with
the protein protocol, and 1 from a C18 eluate that had been processed with the amino acid
protocol, then 2 spots from each of the Porapak columns. All spots were done using just
0.5 l of each eluate, and they were repeated in 2 plates (one plate was run only with the
1st dimension’s solvent, the other was only run with the 2nd dimension’s solvent).
We chose to use the C18 column with the amino acid retrieval protocol (see
results section). We spotted Gla standards, Gla+Glu standards, and Osteocalcin standards
on the TLC plates. On the Gla plate we spotted about 2.5 nmols of a DNS-Gla stock
solution; on the Glu plate we spotted about 5 nmols of the DNS Glu stock solution; on
the Gla+Glu plate we spotted 2.5 nmols of DNS-Gla and 5 nmols of DNS-Glu stock
solutions on the same spot. On the osteocalcin plate we spotted 1.7 nmols of osteocalcin
(previously hydrolyzed and dansylated).
For the fossil samples we took some 80 µl of the fossil stock (described in the
FPLC results section), and hydrolyzed with 100 µl of 2 N NaOH for 22 hours. Then we
neutralized the hydrolysate to pH 7.4, and dansylated it for 4 hours with equal volumes of
750 µg/ml DNS-Cl in acetone. Then we put it through the C18 column with the protein
retrieval protocol and eluted in 0.5 ml of 70% AcN, 0.1% TFA. Then we dried down the
flowthrough of the column, put it again through the C18 column, and re-eluted with the
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protein retrieval protocol. Took 0.5 ml of the DNS-Cl solution blank and put it through
the C18 column using the protein retrieval protocol as well. We dried down both samples,
spotted in the polyamide TLC plate, ran the plate in the solvents of the two dimensions,
and imaged the results.

Liquid Chromatography Mass Spectrometry
From the FPLC elutions of sample BFW, we collected ~1 µg of protein and
placed them in 1.5 mL Eppendorf vials in 15 µL of 0.25% TFA. Samples were analyzed
by means of an autosampler, in the Thermo Scientific LCQ Ion-Trap. The resulting
“RAW” files were further analyzed with the software BioWorks, and the resulting
putative peptides indicated using the software PEAKS (a DE NOVO sequencing program
for interpreting MS/MS results).
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CHAPTER FOUR
RESULTS

The results follow the same sequence in which they were introduced in the section
“Materials and Methods”. Because of the abundance of tests and repeated experiments,
we report here the most prominent results. If there were several repeats of the same step
for one sample, we only show one of the results for the sake of limited space.

Light Microscopy
As the EDTA began working, the fossil bone slowly disappeared. After the bone
matrix was mostly consumed away, what was left was whatever the EDTA could not
dissolve. Figure 4.01 shows the reddish structures in the white bone matrix. Figures 4.024.03 show the liberated vessel-like structures.
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Figure 4.01 - Fossil bone in the progress of demineralization. Vessels (reddish tubular structures)
protrude from the bone matrix, and are not consumed by EDTA, while the matrix continues to
disappear.

Figure 4.02 – Fossil whale vessel casts liberated from bone fragments that had been demineralized
with EDTA (under reflected light).

Figure 4.03 – Branching fossil whale vessel liberated from demineralized bone (using transmited
light). The images seem to suggest that the vessels are hollow (red arrow) and made of some fibrous
material (yellow arrow).
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These results were very surprising. The dissection microscope revealed structures
that very much resemble branching blood-vessels, red-colored, many of them lying on the
bottom of the Petri dish [Fig. 4.02-4.03], but several of them still extending through the
demineralizing fossil bone fragments [Fig. 4.01]. As the EDTA consumed the bone, the
vessel-like structures remained in position, and more prominently protruded from the
fossil bone matrix.
The vessel-like structures were straight or branching and of various thicknesses.
They behaved very much like glass. They would crack as we tried to pick them up with
any metal device, but would not be consumed by the EDTA, even after many days.
We then examined thin-sections of other fossil whale bones from the same
Formation. The microscopy of the thin-sections revealed what clearly resembled
Osteocyte lacunae [Fig. 4.04], and also the porous structure seen in spongy bone.

Scanning Electron Microscopy
Fossil sample BFW showed surprising structural preservation. It displayed vessel
and cell-like structures preservation [Fig. 4.05-4.14]. However, osteocyte and vessel
shapes were also seen in other fossil samples [Fig. 4.15-4.20].
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Figure 4.04 - Fossil whale bone thin sections showing Osteocyte lacunae pattern (under reflected
light).
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Figure 4.05 - Branching vessel structures after demineralization of fossil BFW
bone fragment with EDTA for 3 days.

Figure 4.06 - Interconnected vessel structure remains from demineralized fossil
BFW.
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Figure 4.07 – BFW fossil blood vessel.

Figure 4.08 – Incomplete demineralization of BFW fossil bone. Vessels
protruding outward from bone aligned in the same direction (see arrow).
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Figure 4.09 - BFW close-up of vessels protruding out of demineralizing fossil
bone.

Figure 4.10 – BFW close-up of fossil vessel displaying an osteocyte cell at the
inferior part of the vessel (arrow).
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Figure 4.11 – BFW fossil bone blood vessel surface covered with osteocytes
(arrows).

Figure 4.12 – Fossil osteocyte close-up.
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Figure 4.13 - Osteocytes partially embedded in demineralizing fossil bone
matrix.

Figure 4.14 - Close-up of the fossil osteocyte and its canaliculi (indicated by
arrows) extending downward through the matrix.
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Figure 4.15 - Partially exposed fossil osteocyte from sample EFW.

Figure 4.16 – Fossil osteocyte (see arrow) associated with vessel structure from
sample SP08-20.
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Figure 4.17 – Fossil osteocytes around vessel structure from sample SP08-20.

Figure 4.18 - Completely exposed fossil osteocyte from sample SP08-34.
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Figure 4.19 - Multiple (1) osteocytes from sample SP08-34.

Figure 4.20 – Multiple (2) osteocytes from sample SP08-34.
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X-Ray Diffraction
The XRD results of fossil sample BFW [Fig. 4.21] indicated with a great degree
of confidence that the majority of the material remaining after demineralization, of which
the blood vessels were made of, is quartz. Below is the graph showing the quartz pattern
for this sample.

Biomolecules Extraction
Besides the results showing a certain amount of proteinaceous material per gram
of demineralized fossil material (as shown by BCA), there was also an indication of
lipids in the C18 extraction of sample BFW (EDTA supernatant). Because we wanted to
collect as much proteinaceous material from the sample as reasonably possible, we put
the demineralized solutions (EDTA and GuHCl supernatants) through the C8 columns,
which captured the proteins and peptides in the solution. After the sample flowed
through the C8 column, we put the flowthrough again through a still more hydrophobic
column, the C18 columns. In the “C18 elution from the BFW EDTA fraction”, after we
had partially dried it under nitrogen flow to about 200 µL and after we centrifuged this
dried down solution at 10,000 rcf for 2 minutes, we were surprised to see that the liquid
inside the vial was composed of two phases! The upper phase was clearer and the lower
phase had more of a yellowish appearance. The separation was clearly visible, and the
two phases were distinctly separated.
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Figure 4.21 - XRD results of the remnants of the demineralized fossil bone. Included were blood vessels
and some unidentified material that was not dissolved by EDTA.

This may be an indication that the sample still contains lipids, which were
captured by the C18 column (more hydrophobic than the C8 column). For most of the time
in this research we had only used C8 columns, which are less hydrophobic than the C18,
and therefore, less able to capture lipids than the C18 columns. Only at the final weeks we
used the C18 and realized that lipids might also be present in the fossil samples.

UV Absorbance
Figures 4.22-4.23 show the UV absorption readings of both controls and fossil
samples. In doing the UV assay of the fossil sample BFW, we saw a small absorbance
around 260-280 nm.
Figures 4.24-4.32 show the UV readings of controls and fossils. Due to the large
number of printouts, we are only including the first result of each sample, with the EDTA
and the GuHCl, but not including the many dilutions, which were performed.

94

Absorbance (A)

Absorbance (A)

1.0
0.5
0.0
200.0

250.0

300.0

350.0

400.0

1.0
0.5
0.0
200.0

Wavelength (nm)

250.0

300.0

350.0

400.0

Wavelength (nm)

UV of BFW (SUP3 dilution 4x)

UV of BFW (SUP2 dilution 2x)

3.0

Absorbance (A)

Absorbance (A)

Figure 4.22 – UV absorption of fossil sample BFW (EDTA and GuHCl supernatants).
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Figure 4.23 – UV absorption comparison of fossil bone SP08-23 and its surrounding sediment.
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Figure 4.24 - UV absorption of Chicken EDTA (left) and GuHCl (right) eluates. Especially in the
EDTA fraction there is a prominent peak at around 280 nm, indicative of protein, due to the
characteristic absorbance in that region of aromatic amino acids.

Figure 4.25 - UV absorption of Cow EDTA (left) and GuHCl (right) eluates. The same prominent
peak at around 280 nm is shown here, which indicates the presence of protein.

Figure 4.26 - UV absorption of SB–Whale EDTA (left) and GuHCl (right) eluates. Peaks seen in the
cow and chicken controls around 280 nm are also seen here, but less prominently.
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Figure 4.27 - UV absorption of fossil sample BFW EDTA (left) and GuHCl (right) eluates. There is
some indication of a bend in the curve of the graph around 280 nm, but the implication of such a
small bend may be that there is very little protein in this fossil sample.

Figure 4.28 - UV absorption of fossil sample EFW EDTA (left) and GuHCl (right) eluates. UV
absorption apparently does not distinguish the presence of protein in the sample.

Figure 4.29 - UV absorption of fossil sample SP08-20 EDTA (left) and GuHCl (right) eluates.
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Figure 4.30 - UV absorption of fossil sample SP08-23-Bone EDTA (left) and GuHCl (right) eluates.

Figure 4.31 - UV absorption of fossil sample SP08-23-Sediment EDTA (left) and GuHCl (right)
eluates.

Figure 4.32 - UV absorption of fossil sample SP08-34 EDTA (left) and GuHCl (right) eluates.
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Bicinchoninic Acid Assay
The BCA method, which measures the total protein of a given solution was very
helpful, and extremely consistent. The results for both controls and fossil samples are
shown. The average protein yield in Cow, Chicken and Whale controls are shown in
Figure 4.33. The detailed individual amounts of protein in each supernatant of the control
samples are shown in Figure 4.34.
After testing the standards, we proceeded to assay the fossil samples, but with
experiments several weeks apart. The fossil samples showed a much smaller absorbance
[Fig. 4.35-4.36], relative to the standards, but increased as the amount of starting fossil
material increased.
The detailed amounts of protein in each supernatant of the fossil samples are
shown in Figures 4.37-4.39.
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Figure 4.33 - Protein yields per gram of sample of the Controls, as measured by the Micro BCA assay.

Figure 4.34 - BCA assay of protein amounts in the Eluates of Cow, Chicken and Whale. For samples
“Whale S1 and Whale S3” the absorbance was so high that the instrument was not able to give a
number. The purple color was darker than the 200 g/ml BSA standard, so it follows that the Whale
S1 and S3 had higher protein amounts than 200 µg/ml.
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Figure 4.35 – Average protein yields per gram of Fossil samples
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Figure 4.36 - Protein yields per ml of elution solution of the Fossils

Detailed BCA reading results from fossils EDTA 1 Supernatant:

Figure 4.37 - BCA assay from fossil samples (Supernatant EDTA 1).
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Detailed BCA reading results from fossils EDTA 2 Supernatant:

Figure 4.38 - BCA assay from fossil samples (Supernatant EDTA 2).
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Detailed BCA reading results from fossils GuHCl Supernatant:

Figure 4.39 - BCA assay from fossil samples (Supernatant GuHCl).
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Gels
Gel results from the controls and from the fossil sample BFW are shown in Figure
4.40-4.45. The first gel [Fig. 4.40] is from cow and chicken. The second gel [Fig. 4.41] is
from the SB-Whale. The third [Fig. 4.42] is from an extant whale.
Figure 4.43 is the silver-stained gel from fossil sample BFW. Figure 4.44 is the
same gel re-stained with Coomassie Blue. Figure 4.45 is a new gel altogether from the
same sample BFW sample, stained with just Coomassie Blue.
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Figure 4.40 - Gel of the Controls (Cow and Chicken bones), EDTA and GuHCl C8
elutions.
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Figure 4.41 – Coomassie blue stained gel from extant whale. In this gel we assayed a recent
(and well preserved) whale bone. The characteristic collagen bands are clearly visible (the
two distinct lines on the upper portion of the two central lanes), as well as other bands,
which may correspond to other proteins also present.
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Figure 4.42 – Silver stained gel from SB-Whale. In this gel we assayed a 20-year old Grey
whale skeleton, which had been out under the weather. There are no visible high molecular
bands. Its proteins are very fragmented.
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Silver Stained gel of sample BFW

Figure 4.43 – Silver Stained gel of sample BFW. There were no visible bands in the gel
lanes.
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Figure 4.44 - When re-stained with Coomassie Blue, the gel showed a faint blue line in the
bottom of the protein line, but not as far down as the dye front. This can be indicative that
the proteins preserved in the fossil are in the form of relatively small peptides.
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Figure 4.45 - New attempt to stain proteins extracted from BFW fossil sample, but no success.
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Fast Protein Liquid Chromatography
The FPLC result of the “recent whale” control sample appears in Figure 4.46. The
fossil sample BFW FPLC is shown in Figure 4.47. A close-up view of fossil BFW FPLC
focused at the initial region where higher molecular weight materials would be expected
to elute is shown in figure 4.48. We enlarged the results vertically (notice the scale on the
left side), in order to be able to see the variance, even if it was very small.
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FPLC of “recent whale” control sample

115
Figure 4.46 - FPLC of an extant whale sample. Vials A1-C13 are where the FPLC elution solution was collected for further analysis.

FPLC of sample BFW C8 elution of EDTA + GuHCl combined

116
Figure 4.47 - FPLC chromatogram of sample BFW. The C8 elution fractions of EDTA and GuHCl were combined in order that
the signal would be stronger. Vials A1-C13 are where the FPLC elution solution was collected for further analysis.

Close-up of FPLC of sample BFW C8 elution of EDTA + GuHCl combined
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Figure 4.48 - This is a close-up of the FPLC chromatogram of sample BFW, when the EDTA and GuHCl supernatants were
combined in order to improve the sample's signal. In the close-up, the smaller peaks can be seen, such as the peak between A4 and
A7 labeled “A” pointed out by the arrow. It might reflect the presence of the higher molecular weight materials such as Osteocalcin,
some larger collagen fragments, or some unknown protein fragment. Vials A1-C13 are where the FPLC elution solution was
collected for further analysis.

We pooled the BFW FPLC fractions A4-A8 and labeled it “A”, B8-B11 labeled
“B”, B12-B14 labeled “C”, and B15-C3 labeled “D”. These fractions were combined as
shown in the figure 4.49, and were afterward dried down in order to concentrate them.
The letters “A” through “D” correspond to samples later spotted in the MALDI-TOF
plate and assayed.
Another earlier extraction [Fig. 4.50] of fossil BFW was also run in FPLC in
order to verify the consistency of the results.
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Figure 4.49 - FPLC of sample BFW, with EDTA and GuHCl elutions combined. Letters A-D indicate the fractions that were pooled
together in order to proceed to the MALDI-TOF mass spectrometry analysis of this sample. Vials A1-C13 are where the FPLC
elution solution was collected for further analysis.
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Figure 4.50 - An earlier extraction of sample BFW also showing a peak in the beginning of the chromatogram. This peak may
indicate the presence of higher molecular weight materials in the fossil sample. Vials A1-C13 are where the FPLC elution solution
was collected for further analysis.

Matrix-Assisted Laser Desorption/Ionization-Time of Flight
The blank matrix MALDI-TOF result is shown in Figure 4.51. Control results for
chicken [Fig. 4.52-4.53] and cow [Fig. 4.54-4.55] are also shown.
Figure 4.56 displays the MALDI-TOF result for the fossil whale BFW (EDTA
extraction). The fossil samples shown in figures 4.57-4.60 are the ones that were
subjected to FPLC, which fractions were pooled together.
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Figure 4.51 - MALDI-TOF of just the MALDI matrix used in assisting sample ionization.
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Figure 4.52 - Chicken EDTA 1 MALDI-TOF result. Notice the peak around ~5350 Daltons.
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Figure 4.53 - Chicken GuHCl MALDI-TOF result. Notice the peak around ~5400 Daltons.
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Figure 4.54 - Cow EDTA 2 MALDI-TOF result. Notice peak at ~5780 Daltons.
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Figure 4.55 - Cow GuHCl MALDI-TOF result. Notice peak at ~5790 Daltons.

MALDI-TOF of: Fossil BFW (EDTA extraction)
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Figure 4.56 - MALDI-TOF of BFW EDTA 1, showing some higher molecular weight material around 5400 Daltons.
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Figure 4.57 - MALDI-TOF of FPLC Fraction “C” spotting 4 of fossil sample BFW.

129
Figure 4.58 - MALDI-TOF of FPLC Fraction “C” spotting 5 of fossil sample BFW.
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Figure 4.59 - MALDI-TOF of FPLC Fraction “D”, spotting 1 of fossil sample BFW.
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Figure 4.60 - MALDI-TOF of FPLC Fraction “D” spotting 3 of fossil sample BFW.

Dansylation and Thin-Layer Chromatography
The C18 column gave a higher DNS-amino acid signal, and a lower DNS-OH
signal. Figure 4.61 shows the results of both C18 and Porapak protocols in the 1st
dimension only and Figure 4.62 in the 2nd dimension only.
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Figure 4.61 - DNS-Glu polyamide from C18 and Porapak columns (1st dimension only)
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Figure 4.62 - DNS-Glu polyamide from C18 and Porapak columns (2nd dimension only)
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The results of the controls Gla, Glu, Gla+Glu are shown in Figure 4.63 (the 3
plates run on the 1st dimension). Figure 4.64 compares the 3 plates side-by-side. Figure
4.65 shows the 4 plates run on the 1st dimension. Figure 4.66 compares the 4 plates in
parallel. Figure 4.67 shows the Osteocalcin control plate run in 2 dimensions.
Fossil BFW results are shown in Figure 4.68 (1st dimension of BFW and DNS-Cl
in parallel). Figure 4.69 shows the TLC of the second dimension (DNS-Cl blank and
fossil BFW). A comparison between the fossil BFW plate to the Osteocalcin control plate
is shown in Figure 4.70. The distances traveled by the solvent front, when corrected to be
relatively equivalent in both the Osteocalcin control and the fossil BFW TLC are shown
in figure 4.71.
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Figure 4.63 - The 3 plates (Gla, Glu, and Gla+Glu) run in the 1st dimension, and put corner to
corner for comparison. The arrows indicate the solvent’s direction.

Figure 4.64 - Movement of the amino acids in the 3 plates (parallel view).
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Figure 4.65 - The 4 plates run in the 1st dimension (arrow indicates solvent’s direction).

Figure 4.66 - Movement of the amino acids in the 3 plates (parallel view).
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Figure 4.67 - Hydrolyzed and dansylated amino acids from Osteocalcin TLC: 2nd
dimension.
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Figure 4.68 – 1st dimension of BFW and DNS-Cl TLC. On the left side there is more definition, on
the right side we can see the colors better.

Figure 4.69 – TLC of DNS-Cl blank and BFW on the second dimension.
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Figure 4.70 - Comparison of the traveled distances between osteocalcin and the fossil sample BFW.
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Figure 4.71 - With the adjusted traveled distance, the most prominent spot in the osteocalcin plate
seems to be present in the fossil plate and to have traveled about the same distance.
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Liquid Chromatography Mass Spectrometry
Figure 4.72 shows the BSA fragmentation pattern. BSA standard sequence
matches is shown in figure 4.73. The fossil BFW fragmentation pattern is shown in figure
4.74 and its sequence match in figure 4.75.
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Figure 4.72 - BSA LC/MS. The top part represents the full MS pattern, whereas the bottom section represents
the fragmentary MS/MS pattern. The peaks from around 70 minutes up unto 100 minutes are very
characteristic of peptides.

Mascot Search of LC/MS of BSA Standard

Figure 4.73 - Matching sequences of the standard BSA when compared to a protein database. This
standard was digested with trypsin. There are 7 significant protein hits and dozens of matching
sequences between this standard and the database.
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Figure 4.73 - Continued.
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Figure 4.74 - LC/MS of fossil sample BFW. The upper portion represents the full MS pattern, and the
lower portion represents the MS/MS fragmentation pattern. In the same region that peptides appear in
non-fossil sample, there is positive signal in the fossil sample. The fragmentation pattern in the lower
portion is only due to peptides. If the peaks in fact correspond to peptides, then there are a number of
them still present in the sample.

Mascot Search of LC/MS of Fossil BFW

Figure 4.75 - The fossil sample BFW showed no significant hits, when compared to a database
that looked for trypsin digested peptidic material. This supports the non-contamination approach
used throughout all the course of this study. Because no trypsin was used to digest the fossil
sample, trypsin peptides should not appear, except if there was cross-contamination with
standards.
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CHAPTER FIVE
DISCUSSION

In the microscopy assays of the fossil samples, we observed structures that
resembled red colored blood vessels [Fig. 4.01-4.03]. This is suggestive of the
possibility that the fossil whales might also have other components preserved, such as
high-energy biomolecules (which includes proteins and lipids). In the light microscopy
assays, only the fossil sample “BFW” contained structures that resembled the shape of
blood vessels.
The SEM results revealed a much higher degree of preservation details than what
was seen in light microscopy. It revealed both the vessel-like structures, and also celllike structures. These cells looked very similar to osteocytes in extant bone. There were
also similarities between the fossil vessels and extant vessels:
1. Several of the vessels are branching (as in extant compact bone)
2. The vessels run parallel to the long axis of the bone
3. There are osteocyte-like structures associated with the vessels
Even the fine details present in extant bone such as the canaliculi connecting the
osteocyte cells were seen in the fossil. The conditions that allowed for such a high
degree of preservation are not yet clear. While the EDTA consumed the fossil bone
matrix, it did not consume away the fossil osteocytes.
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The XRD results indicate that the fossil blood vessels are replaced by quartz. In
the Light Microscopy assay we noted that the vessels would crack when picked up by
any metal device. This supports the XRD indication that the vessels are mostly made of
quartz.
As for the C18 extraction of Supernatant 1 being resolved into two phases after
centrifugation, if future experimentation confirms the lipid presence, the implication
would likely be as surprising as the presence of protein in the fossil samples. Besides
lipids being high-energy compounds and especial targets for biomolecular recycling,
they are even less likely to be a contamination from microbes than proteins or peptides.
Whales are full of lipids in their bones, but bacteria and other microbes simply do not
commonly deposit lipids in their environment, which would be too costly.
The UV absorbance of the fossil samples suggests the possibility that the
absorbing amino acids are present in the samples. It shows that there is a greater
absorbance in extracts of the fossil bone than of adjacent sediment [Fig. 4.23]. This
seems to indicate that the fossil bone may have protected its original proteinaceous
content better than the soft issues around it did, such as flesh, baleen, skin, etc.
The amount of protein indicated by the BCA assay as being present in the fossil
samples vary, but all samples have an overall higher protein amount than the sediment
sample (though the sediment sample was taken from a region right adjacent to the bone
sample ~ 0.5 cm away from the edge of the bone). Thus, the BCA results indicate what
the UV absorption results had already suggested: the presence of small, but detectable
amounts of protein in the fossil samples.
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Gels from all the control samples showed typical collagen bands (Fig. 4.404.41). However, in the gel from the 20 year after death weathering whale, we could not
verify the typical collagen bands (Fig. 4.42), not even the least indication of them. There
was a lot of lower molecular weight material, which stained very well, but no bands
which indicated the complete protein. This may be helpful in understanding how
weathered bone shows an immense decrease in original protein content. It might also put
a higher cap to the limit of preservation. It seems that, in order for the collagen bands to
appear, the whale cannot be exposed to the weather, as was this sample, for several
years.
Now when it came to the fossil sample BFW, though we tried several times, we
did not see the same bands in the gel [Fig. 4.43], as we saw in the other samples. But the
reason for this we understood better when we ran the fossil sample through FPLC,
which showed that the sizes of the molecules preserved in the fossils are very small.
Both FPLC and MALDI-TOF showed that most of the material preserved weighs from
1000 to 1300 Daltons, which would correspond to an average of 10-13 amino acids long.
When we took this silver-stained gel from fossil BFW and re-stained it with
Coomassie blue [Fig. 4.44], we could see something that we didn’t expect. Down below,
where the very small peptides would be, we saw a faint blue line, which could be
indicative that the material inside the fossil samples is but only a few amino acids long.
We tried running the gel all over again and staining it only with Coomassie Blue
[Fig. 4.45], but the results weren’t any more elucidating. There were no bands
whatsoever on the upper portion of the gel, which could be because there were no
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proteins large enough to be in the upper portion, or because they weren’t enough to
show a visible band, or because they didn’t stain.
So we decided that gels were not the most appropriate approach when dealing
with fossil material. This was also concluded by Schweitzer as she obtained 8 peptide
sequences (Schweitzer et al. 2009) from the dinosaur sample without using gel, but only
1 peptide sequence (described in the Supplement of the same paper) when extracting
them from gel. In our study, while gel didn’t seem to give any positive indication that
the proteins are present in the fossil, other methods indicated that protein material is
there, but we reasoned that they are either too small in size or too little in abundance to
stain and be as visible as the proteins from the controls. Fortunately, there were other
means of testing if peptides/proteins were present or not in the fossil samples. These
other methods were more sensitive, and also relatively more informative. They included
FPLC, MALDI-TOF, LCQ, and TLC.
The recent whale doesn’t show discrete peaks as seen in the fossil sample results.
This could be because in the recent whale there is a great variety of different peptides,
from the breakdown of the larger proteins, resulting in not so discrete peaks. If these
peptides are in large concentrations, it would be expected that large peaks would
obliterate the display of smaller ones right adjacent to them. Both of these ideas are in
agreement with the fact that in recent samples there should be a variety of proteins
present, which have not decayed away, but are in the process of breaking down. This
process would yield many different fragments of proteins preventing the appearance of
discrete peaks.
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Fossil sample BFW FPLC results displayed peaks consistent with the presence of
peptides (Fig. 4.47). The peaks were right where they were expected in a control sample
peptide graph.
Based on this chromatogram and the data obtained from the UV and BCA
assays, we may deduce that there are small sized but yet abundant putative peptidic
material in the sample. The majority of it is smaller than 2,000 Daltons, and there
appears to be discrete peaks, which may suggest that the peptides vary in size. There is
enough relative abundance of each type or cluster of peptides so that individual peaks
can be distinguished in the FPLC output.
If the sample had anything larger than 7,000 Daltons, it would come out and be
chromatographed around vials A4 and A5. That’s where the large molecular weight
material should appear. When we take a close-up look (Fig. 4.48) at that region, we see
that there is a small, but not random, peak at the end of the void volume. This peak
appears between fractions A5–A6. It may reflect the presence of Osteocalcin in the
fossil extract or at least some larger molecular weight protein fragments. The relatively
large peaks in the regions from B1–C10, may indicate the presence of peptides in
various sizes. The putative peptidic presence is in agreement with the BCA assay results.
The fractions that were eluted from the FPLC were combined as shown in the
figure 4.49, and were afterward dried down in order to concentrate them. The letters “A”
through “D” correspond to samples later spotted in the MALDI-TOF plate and assayed.
Both this BFW extraction [Fig. 4.48] and also an earlier extraction [Fig. 4.50]
show a similar peak in the beginning of the chromatogram after the void volume. This
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peak may correspond to larger peptides or almost complete small proteins that elute
early following the void volume because of the type of column used.
There is much less material in the region where Osteocalcin or some larger
protein fragments would be than in the region where would be the smaller peptides. This
could mean that the majority of the molecules present in the fossil sample extract are
very fragmented, but that there is a small presence of the higher molecular weight
material. Regardless of peak sizes, the FPLC results are consistent with the presence of
peptides in the fossil sample.
The MALDI-TOF results were much more elucidative than any other type of
experiment we had previously done. There was indication of higher molecular weight
materials in the fossil samples, such as Osteocalcin, which has a molecular weight
~5800 Daltons in extant samples. The chicken [Fig. 4.51-4.52] and cow [Fig. 4.53-4.54]
controls showed peaks at similar ranges where one would expect Osteocalcin to show
up. The cow peaks are closer to the ~5800 Daltons commonly attributed to Osteocalcin
than the chicken. However, even if they are not exactly alike, the pattern seen in the cow
peaks is similar to the pattern in the chicken peaks. This could be some size variation in
this protein across species, as seen in our samples.
Something to consider in the fossil sample is that the C8 EDTA elution of the
sample “BFW” [Fig. 4.56] displayed a peak at ~5400 Daltons, which possibly suggests
that remnants of the protein Osteocalcin may still be present in the fossil sample, as
there have been previous reports of Osteocalcin in fossils (Ulrich et al. 1987; Huq et al.
1990; Muyzer et al. 1992; Collins et al. 2000; Nielsen-Marsh et al. 2002). One thing to
note though is that we were only able to see this in one extraction of sample “BFW”
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using MALDI-TOF, and possibly in two other extractions using the FPLC column [Fig.
4.48 and 4.50].
The reason for this in the case of MALDI-TOF may be because the extraction
solution we used when the peak showed up was not concentrated, but was just eluted out
of the C8 column, whereas all the other times when we tested the extraction with
MALDI-TOF, the solutions had been previously concentrated down using a laminar
flow of nitrogen. This might have caused the proteins to clump together and, due to its
specific chemical properties, come out of solution.
Another consideration in the fossil sample is that it could be composed of very
fragmented proteinaceous materials, which would not be seen in the higher range of the
MALDI-TOF, but only in the peptide range. In accordance with that, we point out that
when we used the peptide method (instead of the protein method) to analyze the fossil
elution, we saw peaks consistent with the FPLC results. The peaks presented very
consistent sizes (which were absent in the blank results, i.e. they were extra peaks found
in the fossil sample BFW).
We see in the plain matrix or “the blank” [Fig. 4.51], which is used in assisting
the sample molecules to be ionized and fly off the plate, its characteristic peaks. These
peaks are related to the sizes of the materials composing the matrix solution and their
interaction with each other. The largest considerable peaks (visible as a peak and not just
as a number in the list of numbers) range up to ~909 Daltons.
Now compare this to the fossil peaks [Fig. 4.57-4.60]. Clearly there are
indications that the fossil has some extra peaks (corresponding to molecules that are
present in the sample) aside from those present in the matrix. These fossil samples are
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the ones that were subjected to FPLC analysis, which had their fractions were pooled
together.
Some peaks shown in the MALDI-TOF output, but absent in the matrix include:
927, 1033, 1052, 1077, 1096, 1106, 1161, 1287, 1310, 1349, 1498, and 1538 Daltons.
These are not including anything below the 908 Daltons (highest blank matrix peak
shown seen in Fig. 4.51). There are slight variations in the fossil peaks (1-2 Daltons),
but they seem to be quite consistent throughout the analysis. The identification of peaks
that are not in the blank but that are in the fossil is consistent with the presence of
peptides in the fossil sample BFW.
MALDI-TOF seems to be supportive of the presence of small and fragmented
peptides in the fossil sample BFW, besides those that are present in the blank.
The dansylation protocol was only partially elucidative. The first point we saw
was that instead of using Porapak columns for the procedure, we had better preliminary
results with the C18 columns. The C18 column gave a higher DNS-amino acid signal
(what we want to see), and a lower DNS-OH signal (what we want to get rid of) [Fig.
4.61 and 4.62].
Running the experiment with C18 column using the amino acid retrieval protocol
is more efficient for removing the DNS-OH and keeping the DNS-Glu than the Porapak
column procedure.
When the DNS-Cl (the blank) is compared to the fossil sample BFW [Fig. 4.69],
it is obvious that the fossil has some extra material than the blank. If we compare the
BFW plate to the Osteocalcin plate [Fig. 4.70] there are some interesting similarities and
also differences. The differences appear in the number of visible spots. The Osteocalcin
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control has about a dozen visible marks, whereas the fossil BFW sample only shows 4-5
spots. This could be due to the fact that the fossil has been decaying and not all amino
acids are present in enough amounts to result in a visible spot for each one. The fossil
may or may not have all the amino acids, but because they might be present in such low
quantities, it may not be possible to detect them using this method.
An important similarity though is evident when we digitally correct the solvent’s
front traveled distance to match between both the control and the fossil sample plates
[Fig. 4.71]. The distance traveled by the solvent front can be affected by external factors,
and not by the sample alone. There is a ratio between the traveled distance of the solvent
front and the traveled distance of each spot. However, we can digitally correcte the
traveled fronts by stretching the image, and the spots behave as if they had traveled
accordingly as well. If we digitally adjust the solvent’s traveled distance to account for
the smaller total travel length in the Osteocalcin TLC as relative to the fossil TLC, the
amino acid in highest abundance in the Osteocalcin standard is located right where is
located the only one visible in the fossil TLC. Their most prominent spots seem to have
traveled similar distances. The spot in the fossil plate is almost the only one seen in the
plate (except for the spot of unknown composition located at the top-left corner). If the
brightest spot in the Osteocalcin control plate corresponds to the brightest spot in the
fossil BFW plate, then, it is possible that the fossil didn’t have enough material to
display all amino acids such as the ones shown in the control, but only the most
prominent one, and the others are too faint to be noticed in this assay.
The support of the TLC assay for the presence of amino acids in the fossil
samples is not as evident and straightforward as are the previously reported assays.
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Nevertheless, it still offers some level of support as shown by the equivalent distance
traveled by the most prominent spots.
The LC/MS results are very extensive, and the data technically demanding. In a
trial run of the DE NOVO sequencing there were over 11,000 entries or putative amino
acid sequences found in the fossil sample BFW LC/MS. The confidence level of the
majority of those fragments is not high, but there are some, which present higher degrees
of confidence of yielded sequence.
The process of analyzing those sequences can be extremely time-consuming, and
demands an expertise that is not readily available. This particular step may require
considerable more effort than initially thought, rendering it more appropriate for a
doctoral dissertation, or a multidisciplinary approach, that is, mass spectrometry trained
people in conjunction with biochemistry and paleontology.
Nevertheless, we included in the results the overall fragmentation pattern
obtained from both the BSA standard and from the fossil sample BFW. When the BSA
LC/MS output result was searched at the protein database (Mascot, from Matrix
Science), there were over 7 protein hits, with dozens of matching sequences [Fig. 4.72],
indicating that the system correctly identified the LC/MS results for the BSA standard.
The search was performed by selecting trypsin as the enzyme responsible for the
digestion of the BSA protein. The fragmentation pattern seen in the secondary ms/ms is
characteristic of peptidic material (lower half of Fig. 4.73).
When we were performing the search with the fossil sample BFW LC/MS
results, we realized that we did not have an option for choosing “no enzyme” in the
search system. Although the fossil was fragmented, the fragmentation process was not
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specifically done by trypsin or any other specific enzyme, but by means of random
processes, of which we have no current knowledge. As we performed the search (using
trypsin as the enzyme responsible for digestion), there were absolutely no significant
hits, with zero matching sequences to anything, implying that the system did not identify
any peptide fragments that were cleaved by trypsin.
This result makes sense because the search was only looking for trypsin digested
peptides. It is evident, therefore, that there was no cross contamination between the BSA
standard and the fossil sample, for if there were, the trypsin digested fragments would be
pointed out. The implication is that, whatever we find in the fossil sample BFW LC/MS
output when trying to reconstruct the peptide fragments by means of the DE NOVO
sequencing belongs to the fossil, or at least, is not a contamination from the standard.
The fragmentation pattern of the fossil sample BFW (Fig. 4.74) is happening in
the same region that it usually happens when extant proteins are analyzed. Secondary
fragmentation is happening, which indicates that the material we are dealing with is
composed of peptides. This is very important in determining the nature of the material
from fossil BFW, which has already been indicated in the previous assays such as BCA,
FPLC and MALDI-TOF. The sum of factors suggests that the material consists of
peptides/proteins and actually behave as that. The LC/MS assay was a further
confirmation of the previous steps in the analysis of fossil sample BFW.
As to which peptides or sequences they specifically represent, may be a question
more appropriate for a more in-depth study, and not feasible for a masters program.
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CHAPTER SIX
CONCLUSION

The fossil whales of the Pisco Formation are of import, not only from an
inorganic, sedimentary perspective, but also from the organic, molecular, and
ultrastructural perspective. In addition to still articulated bones and the presence of fossil
baleen in life position, the results of the experiments in this current study suggest that
there is also a certain level of biomolecular preservation.
Because of the altered nature of animal remains found in the fossil record, they
are far more complex to analyze than extant samples. There is potential for a lot of
change to happen in the course of time of which we may have no idea. Even though we
can do repeated experiments, it is not with absolute certainty that conclusions can be
drawn. Nevertheless, some conclusion may prove of value.
One of these conclusions is that when working with fossil candidates for
extensive experimentation, screening them with even a light microscope may prove to
be very timesaving (the promising samples may be more easily indicated). In this study,
the microscopy assay showed that blood vessel structures and osteocyte shapes were still
present in some of the samples. The composition of the vessels was indicated by XRD to
be quartz. This may imply that silica-rich fluids have passed through the sample and
precipitated. The extent of this silica deposition is not complete, for there is still some
organic material present in the samples, as indicated by the protein/peptide assays.
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The preservation of fossil osteocytes is also of relevance, especially because of
the abundance seen in these samples. Just like the fossil blood vessel structure, these
osteocytes were also not consumed when subjected to EDTA. Both may have the same
constitution, or at least, may have been partially substituted by the same minerals. If the
samples had been in an aqueous environment too long, these structures could have been
decomposed, and the fine details could have been lost (Allison et al. 1991; Brand et al.
2003; Trueman et al. 2003).
Unlike the surprising T-rex sample (Schweitzer et al. 2005), which contained
still soft and pliable original tissue, our samples, after partial demineralization remained
brittle, implying that much of the organic material had been substituted by mineral
components. In spite of that, we still observed well-preserved morphological features
and evidence of proteinaceous, as well as lipid, material.
The level of proteinaceous preservation in the fossil samples analyzed in this
study varied considerably. Nevertheless, it is worthy of notice that when fossil sediment
was compared to fossil bone, even though the sediment sample was located immediately
adjacent to the fossil bone, it presented an average protein concentration below that
present in all fossil bones analyzed, including those badly preserved, implying that the
fossil bone provided a better environment for biomolecular preservation than its
surroundings. The detection of preserved proteinaceous material from the fossil bone
samples is supported by the BCA assay, the TLC analysis, the FPLC profile, the
MALDI-TOF mass spectra, and the LC/MS results (especially the secondary
fragmentation pattern characteristically observed in peptidic material). In addition to
extracted proteinaceous material, there was also indication of lipid preservation in the
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C18 extraction of the EDTA supernatant from the fossil sample BFW. This is consistent
with a number of reported lipid findings in fossil samples (Das et al. 1967; Mackenzie et
al. 1982; Eglinton et al. 1991; Briggs et al. 2000).
We conclude that this study contributed to the growing body of knowledge of the
fossil whales from the Pisco Formation and of the extent of preservation found in them.
Although the previously assigned geologic ages to these whales did not encourage
searching for biomolecules in them, the actual results of these experiments are
supportive of the presence of peptides/protein fragments in these fossil whales. Much
more research can and should be done to determine with greater depth the extent of
preservation of both the ultrastructure and the organic remains of the fossil whales from
the Pisco Formation.
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